Cover
Cover - USD ($) | 12 Months Ended | ||
Mar. 25, 2023 | May 17, 2023 | Sep. 24, 2022 | |
Cover [Abstract] | |||
Document Type | 10-K | ||
Document Annual Report | true | ||
Document Period End Date | Mar. 25, 2023 | ||
Current Fiscal Year End Date | --03-25 | ||
Document Transition Report | false | ||
Entity File Number | 0-17795 | ||
Entity Registrant Name | CIRRUS LOGIC, INC. | ||
Entity Incorporation, State or Country Code | DE | ||
Entity Tax Identification Number | 77-0024818 | ||
Entity Address, Address Line One | 800 W. 6th Street | ||
Entity Address, City or Town | Austin, | ||
Entity Address, State or Province | TX | ||
Entity Address, Postal Zip Code | 78701 | ||
City Area Code | (512) | ||
Local Phone Number | 851-4000 | ||
Title of 12(b) Security | Common stock, $0.001 par value | ||
Trading Symbol | CRUS | ||
Security Exchange Name | NASDAQ | ||
Entity Well-known Seasoned Issuer | Yes | ||
Entity Voluntary Filers | No | ||
Entity Current Reporting Status | Yes | ||
Entity Interactive Data Current | Yes | ||
Entity Filer Category | Large Accelerated Filer | ||
Smaller Reporting Company | false | ||
Emerging Growth Company | false | ||
ICFR Auditor Attestation Flag | true | ||
Entity Shell Company | false | ||
Entity Public Float | $ 2,621,830,483 | ||
Entity Common Stock, Shares Outstanding (in shares) | 54,814,364 | ||
Documents Incorporated by Reference | Certain information contained in the registrant’s proxy statement for its annual meeting of stockholders to be held July 28, 2023 is incorporated by reference in Part II – Item 5 and Part III of this Annual Report on Form 10-K. | ||
Amendment Flag | false | ||
Entity Central Index Key | 0000772406 | ||
Document Fiscal Year Focus | 2023 | ||
Document Fiscal Period Focus | FY |
Audit Information
Audit Information | 12 Months Ended |
Mar. 25, 2023 | |
Audit Information [Abstract] | |
Auditor Firm ID | 42 |
Auditor Name | Ernst & Young LLP |
Auditor Location | Austin, Texas |
Consolidated Balance Sheets
Consolidated Balance Sheets - USD ($) $ in Thousands | Mar. 25, 2023 | Mar. 26, 2022 |
Current assets: | ||
Cash and cash equivalents | $ 445,784 | $ 369,814 |
Marketable securities | 34,978 | 10,601 |
Accounts receivable, net | 150,473 | 240,264 |
Inventories | 233,450 | 138,436 |
Prepaid assets | 35,507 | 40,822 |
Prepaid wafers | 60,638 | 0 |
Other current assets | 57,026 | 40,078 |
Total current assets | 1,017,856 | 840,015 |
Long-term marketable securities | 36,509 | 63,749 |
Right-of-use lease assets | 128,145 | 171,003 |
Property and equipment, net | 162,972 | 157,077 |
Intangibles, net | 38,876 | 158,145 |
Goodwill | 435,936 | 435,791 |
Deferred tax assets | 35,580 | 11,068 |
Long-term prepaid wafers | 134,363 | 195,000 |
Other assets | 73,729 | 91,552 |
Total assets | 2,063,966 | 2,123,400 |
Current liabilities: | ||
Accounts payable | 81,462 | 115,417 |
Accrued salaries and benefits | 50,606 | 65,261 |
Software license agreements | 20,948 | 21,736 |
Current lease liabilities | 18,442 | 14,680 |
Acquisition-related liabilities | 21,361 | 30,964 |
Other accrued liabilities | 23,521 | 16,725 |
Total current liabilities | 216,340 | 264,783 |
Long-term liabilities: | ||
Non-current lease liabilities | 122,631 | 163,162 |
Non-current income taxes | 59,013 | 73,383 |
Long-term acquisition-related liabilities | 0 | 8,692 |
Other long-term liabilities | 7,700 | 13,563 |
Total long-term liabilities | 189,344 | 258,800 |
Stockholders’ equity: | ||
Preferred stock, 5.0 million shares authorized but unissued | 0 | 0 |
Common stock, $0.001 par value, 280,000 shares authorized, 55,098 shares and 56,596 shares issued and outstanding at March 25, 2023 and March 26, 2022, respectively | 55 | 57 |
Additional paid-in capital | 1,670,086 | 1,578,370 |
Accumulated earnings (deficit) | (9,320) | 23,435 |
Accumulated other comprehensive loss | (2,539) | (2,045) |
Total stockholders’ equity | 1,658,282 | 1,599,817 |
Total liabilities and stockholders’ equity | $ 2,063,966 | $ 2,123,400 |
Consolidated Balance Sheets (Pa
Consolidated Balance Sheets (Parenthetical) - $ / shares shares in Thousands | Mar. 25, 2023 | Mar. 26, 2022 |
Statement of Financial Position [Abstract] | ||
Preferred stock, shares authorized but unissued (in shares) | 5,000 | 5,000 |
Common stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Common stock, shares authorized (in shares) | 280,000 | 280,000 |
Common stock, shares issued (in shares) | 55,098 | 56,596 |
Common stock, shares outstanding (in shares) | 55,098 | 56,596 |
Consolidated Statements of Inco
Consolidated Statements of Income - USD ($) shares in Thousands, $ in Thousands | 12 Months Ended | ||
Mar. 25, 2023 | Mar. 26, 2022 | Mar. 27, 2021 | |
Income Statement [Abstract] | |||
Net sales | $ 1,897,617 | $ 1,781,460 | $ 1,369,230 |
Cost of sales | 940,638 | 857,819 | 661,929 |
Gross profit | 956,979 | 923,641 | 707,301 |
Operating expenses | |||
Research and development | 458,412 | 406,307 | 342,759 |
Selling, general and administrative | 153,144 | 150,996 | 127,008 |
Lease impairments and restructuring | 10,632 | 0 | 352 |
Intangibles impairment | 85,760 | 0 | 0 |
Total operating expenses | 707,948 | 557,303 | 470,119 |
Income from operations | 249,031 | 366,338 | 237,182 |
Interest income | 9,985 | 1,563 | 6,281 |
Interest expense | (898) | (948) | (1,057) |
Other income (expense) | (3,379) | 1,710 | 2,840 |
Income before income taxes | 254,739 | 368,663 | 245,246 |
Provision for income taxes | 78,036 | 42,308 | 27,902 |
Net income | $ 176,703 | $ 326,355 | $ 217,344 |
Basic earnings per share (in dollars per share) | $ 3.18 | $ 5.70 | $ 3.74 |
Diluted earnings per share (in dollars per share) | $ 3.09 | $ 5.52 | $ 3.62 |
Basic weighted average common shares outstanding (in shares) | 55,614 | 57,278 | 58,106 |
Diluted weighted average common shares outstanding (in shares) | 57,226 | 59,143 | 60,060 |
Consolidated Statements of Comp
Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands | 12 Months Ended | ||
Mar. 25, 2023 | Mar. 26, 2022 | Mar. 27, 2021 | |
Statement of Comprehensive Income [Abstract] | |||
Net income | $ 176,703 | $ 326,355 | $ 217,344 |
Other comprehensive income (loss), before tax | |||
Foreign currency translation gain (loss) | (834) | (507) | 1,862 |
Unrealized gain (loss) on marketable securities | 430 | (5,587) | 5,673 |
Benefit (provision) for income taxes | (90) | 1,174 | (1,191) |
Comprehensive income | $ 176,209 | $ 321,435 | $ 223,688 |
Consolidated Statements of Cash
Consolidated Statements of Cash Flows - USD ($) $ in Thousands | 12 Months Ended | ||
Mar. 25, 2023 | Mar. 26, 2022 | Mar. 27, 2021 | |
Cash flows from operating activities: | |||
Net income | $ 176,703 | $ 326,355 | $ 217,344 |
Adjustments to net cash provided by operating activities: | |||
Depreciation and amortization | 71,202 | 62,061 | 47,083 |
Stock-based compensation expense | 81,641 | 66,392 | 56,762 |
Deferred income taxes | (34,513) | (15,002) | (5,581) |
Loss on retirement or write-off of long-lived assets | 656 | 642 | 371 |
Other non-cash (gains) / charges | 3,102 | 370 | (622) |
Lease impairments and restructuring | 10,632 | 0 | 352 |
Intangibles impairment | 85,760 | 0 | 0 |
Net change in operating assets and liabilities: | |||
Accounts receivable, net | 89,791 | (124,826) | 45,286 |
Inventories | (95,014) | 42,502 | (26,538) |
Prepaid wafers | 0 | (195,000) | 0 |
Other assets | 1,852 | (92,584) | 843 |
Accounts payable | (34,307) | 10,529 | 21,104 |
Accrued salaries and benefits | (15,108) | 10,049 | 12,410 |
Income taxes payable | (6,019) | (804) | (18,185) |
Acquisition-related liabilities | 12,654 | 39,656 | 0 |
Other accrued liabilities | (9,464) | (5,587) | (1,684) |
Net cash provided by operating activities | 339,568 | 124,753 | 348,945 |
Cash flows from investing activities: | |||
Maturities and sales of available-for-sale marketable securities | 18,683 | 371,545 | 168,328 |
Purchases of available-for-sale marketable securities | (15,299) | (83,023) | (225,528) |
Purchases of property, equipment and software | (35,090) | (26,139) | (18,253) |
Investments in technology | (1,624) | (3,871) | (2,222) |
Acquisition of business, net of cash obtained | 0 | (276,884) | 0 |
Net cash used in investing activities | (33,330) | (18,372) | (77,675) |
Cash flows from financing activities: | |||
Debt issuance costs | 0 | (1,718) | 0 |
Payment of acquisition-related holdback | (30,949) | 0 | 0 |
Issuance of common stock, net of shares withheld for taxes | 10,145 | 13,220 | 7,128 |
Repurchase of stock to satisfy employee tax withholding obligations | (18,082) | (22,732) | (18,367) |
Repurchase and retirement of common stock | (191,382) | (167,501) | (109,986) |
Net cash used in financing activities | (230,268) | (178,731) | (121,225) |
Net increase (decrease) in cash and cash equivalents | 75,970 | (72,350) | 150,045 |
Cash and cash equivalents at beginning of period | 369,814 | 442,164 | 292,119 |
Cash and cash equivalents at end of period | 445,784 | 369,814 | 442,164 |
Cash payments during the year for: | |||
Income taxes | 91,955 | 35,693 | 28,988 |
Interest | $ 537 | $ 572 | $ 610 |
Consolidated Statements of Stoc
Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands | Total | Common Stock | Additional Paid-In Capital | Accumulated Earnings (Deficit) | Accumulated Other Comprehensive Income / (Loss) |
Beginning balance (in shares) at Mar. 28, 2020 | 58,242 | ||||
Balance at Mar. 28, 2020 | $ 1,229,779 | $ 58 | $ 1,434,871 | $ (201,681) | $ (3,469) |
Net income | 217,344 | 217,344 | |||
Change in unrealized gain (loss) on marketable securities, net of tax | 4,482 | 4,482 | |||
Change in foreign currency translation adjustments | 1,862 | 1,862 | |||
Issuance of stock under stock option plans and other, net of shares withheld for employee taxes (in shares) | 862 | ||||
Issuance of stock under stock option plans and other, net of shares withheld for employee taxes | (11,238) | $ 1 | 7,128 | (18,367) | |
Repurchase and retirement of common stock (in shares) | (1,452) | ||||
Repurchase and retirement of common stock | (109,986) | $ (1) | (109,985) | ||
Amortization of deferred stock compensation | 56,762 | 56,762 | |||
Ending balance (in shares) at Mar. 27, 2021 | 57,652 | ||||
Balance at Mar. 27, 2021 | 1,389,005 | $ 58 | 1,498,761 | (112,689) | 2,875 |
Net income | 326,355 | 326,355 | |||
Change in unrealized gain (loss) on marketable securities, net of tax | (4,413) | (4,413) | |||
Change in foreign currency translation adjustments | (507) | (507) | |||
Issuance of stock under stock option plans and other, net of shares withheld for employee taxes (in shares) | 1,008 | ||||
Issuance of stock under stock option plans and other, net of shares withheld for employee taxes | (9,514) | $ 1 | 13,217 | (22,732) | |
Repurchase and retirement of common stock (in shares) | (2,064) | ||||
Repurchase and retirement of common stock | (167,501) | $ (2) | (167,499) | ||
Amortization of deferred stock compensation | 66,392 | 66,392 | |||
Ending balance (in shares) at Mar. 26, 2022 | 56,596 | ||||
Balance at Mar. 26, 2022 | 1,599,817 | $ 57 | 1,578,370 | 23,435 | (2,045) |
Net income | 176,703 | 176,703 | |||
Change in unrealized gain (loss) on marketable securities, net of tax | 340 | 340 | |||
Change in foreign currency translation adjustments | (834) | (834) | |||
Issuance of stock under stock option plans and other, net of shares withheld for employee taxes (in shares) | 861 | ||||
Issuance of stock under stock option plans and other, net of shares withheld for employee taxes | $ (7,936) | $ 1 | 10,141 | (18,078) | |
Repurchase and retirement of common stock (in shares) | (2,400) | (2,359) | |||
Repurchase and retirement of common stock | $ (191,383) | $ (3) | (191,380) | ||
Amortization of deferred stock compensation | 81,575 | 81,575 | |||
Ending balance (in shares) at Mar. 25, 2023 | 55,098 | ||||
Balance at Mar. 25, 2023 | $ 1,658,282 | $ 55 | $ 1,670,086 | $ (9,320) | $ (2,539) |
Description of Business
Description of Business | 12 Months Ended |
Mar. 25, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Description of Business | Description of Business Description of Business Cirrus Logic, Inc. (“Cirrus Logic,” “We,” “Us,” “Our,” or the “Company”) is a leader in low-power, high-precision mixed-signal processing solutions that create innovative user experiences for the world’s top mobile and consumer applications. We were incorporated in California in 1984, became a public company in 1989, and were reincorporated in the State of Delaware in February 1999. Our primary facility housing engineering, sales and marketing, and administration functions is located in Austin, Texas. We also have offices in various other locations in the United States, United Kingdom, and Asia, including the People’s Republic of China, South Korea, Japan, Singapore, and Taiwan. Our common stock, which has been publicly traded since 1989, is listed on the NASDAQ's Global Select Market under the symbol CRUS. Basis of Presentation We prepare financial statements on a 52- or 53-week year that ends on the last Saturday in March. Fiscal years 2023, 2022, and 2021 were 52-week years. The next 53-week year will be fiscal year 2024. Principles of Consolidation The accompanying consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (U.S. GAAP) and include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated. Reclassifications Certain reclassifications have been made to prior year balances in order to conform to the current year’s presentation of financial information. Use of Estimates The preparation of financial statements in accordance with U.S. GAAP requires the use of management estimates. These estimates are subjective in nature and involve judgments that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at fiscal year-end and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from these estimates. |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 12 Months Ended |
Mar. 25, 2023 | |
Accounting Policies [Abstract] | |
Summary of Significant Accounting Policies | Summary of Significant Accounting Policies Cash and Cash Equivalents Cash and cash equivalents consist primarily of money market funds, commercial paper, and U.S. Government Treasury and Agency instruments with original maturities of three months or less at the date of purchase. Business Combinations We account for business combinations using the acquisition method of accounting and allocate the fair value of acquisition consideration to the assets acquired and liabilities assumed based on their fair values at the acquisition date. The excess of the fair value of purchase consideration over the fair value of the assets acquired and liabilities assumed is recorded as goodwill. The results of operations of the business acquired is included in our consolidated statements of income beginning on the date of the acquisition. Leases We account for leases under ASC 842, Leases. Our leases generally contain fixed rental payments, with additional variable payments linked to actual common area maintenance costs incurred by the landlord. These variable payments are not included within the lease liability and right-of-use ("ROU") asset, but are recognized as an expense when incurred. As our leases typically do not provide an implicit rate, the Company determines the Incremental Borrowing Rate ("IBR") for each lease based on the information available at the commencement date, taking into consideration necessary adjustments for collateral, currency, and lease term. Operating leases in excess of 12 months are recognized on the balance sheet, with future lease payments recognized as a liability, measured at present value, and the ROU asset recognized for the lease term. Lease expense is recognized in the income statement over the lease term. Inventories We use the lower of cost or net realizable value to value our inventories, with cost being determined on a first-in, first-out basis. One of the factors we consistently evaluate in the application of this method is the extent to which products are accepted into the marketplace. By policy, we evaluate market acceptance based on known business factors and conditions by comparing forecasted customer unit demand for our products over a specific future period, or demand horizon, to quantities on hand at the end of each accounting period. On a quarterly and annual basis, we analyze inventories on a part-by-part basis. Product life cycles and the competitive nature of the industry are factors considered in the evaluation of customer unit demand at the end of each quarterly accounting period. Inventory on-hand in excess of forecasted demand is considered to have reduced market value and, therefore, the cost basis is adjusted to the lower of cost or net realizable value. Typically, market values for excess or obsolete inventories are considered to be zero. Inventory charges recorded for excess and obsolete inventory, including scrapped inventory, were $9.9 million and $6.5 million, in fiscal year 2023 and 2022, respectively. Inventory charges in fiscal year 2023 and 2022 related to a combination of quality issues and inventory exceeding demand. Inventories were comprised of the following (in thousands): March 25, 2023 March 26, 2022 Work in process $ 116,088 $ 95,188 Finished goods 117,362 43,248 $ 233,450 $ 138,436 Property, Plant and Equipment, net Property, plant and equipment is recorded at cost, net of depreciation and amortization. Depreciation and amortization is calculated on a straight-line basis over estimated economic lives, ranging from 3 to 39 years. Leasehold improvements are depreciated over the shorter of the term of the lease or the estimated useful life. Furniture, fixtures, machinery, and equipment are all depreciated over a useful life of 3 to 10 years, while buildings are depreciated over a period of up to 39 years. In general, our capitalized software is amortized over a useful life of 3 years, with capitalized enterprise resource planning software being amortized over a useful life of 10 years. Gains or losses related to retirements or dispositions of fixed assets are recognized in the period incurred. Additionally, if impairment indicators exist, the Company will assess the carrying value in relation to the calculated fair value of the associated asset. The Company recorded $1.3 million of property, plant and equipment charges during fiscal year 2023, related to restructuring. See Note 12 — Lease Impairments and Restructuring for further detail. There were no additional material disposal charges for property, plant and equipment in fiscal years 2023, 2022 or 2021. Property, plant and equipment was comprised of the following (in thousands): March 25, 2023 March 26, 2022 Land $ 23,853 $ 23,853 Buildings 64,056 63,730 Furniture and fixtures 23,909 24,122 Leasehold improvements 55,733 53,611 Machinery and equipment 188,403 175,966 Capitalized software 26,889 26,491 Construction in progress and other 14,350 5,566 Total property, plant and equipment 397,193 373,339 Less: Accumulated depreciation and amortization (234,221) (216,262) Property, plant and equipment, net $ 162,972 $ 157,077 Depreciation and amortization expense on property, plant, and equipment for fiscal years 2023, 2022, and 2021 was $27.1 million, $24.8 million, and $24.9 million, respectively. Goodwill Goodwill is recorded at the time of an acquisition and is calculated as the difference between the aggregate consideration paid for an acquisition and the fair value of the net tangible and intangible assets acquired. The Company tests goodwill for impairment on an annual basis or more frequently if the Company believes indicators of impairment exist. Impairment evaluations involve management’s assessment of qualitative factors to determine whether it is more likely than not that goodwill is impaired. If management concludes from its assessment of qualitative factors that it is more likely than not that impairment exists, then a quantitative impairment test will be performed involving management estimates of future cash flows. Significant management judgment is required in the forecasts of future operating results that are used in these evaluations. Following the quantitative test, an impairment charge would be recorded for the amount the carrying value exceeds the calculated fair value. The Company has recorded no goodwill impairment in fiscal years 2023, 2022, and 2021. Long-Lived Assets Intangible assets include purchased technology licenses and patents that are reported at cost and are amortized on a straight-line basis over their useful lives, generally ranging from 1 to 5 years. Acquired intangibles include existing technology, core technology or patents, license agreements, in-process research & development, trademarks, tradenames, customer relationships, and non-compete agreements. These assets are amortized on a straight-line basis over lives ranging from 1 to 15 years. We regularly review whether facts or circumstances exist that indicate the carrying values of property, plant and equipment or other long-lived assets, including intangible assets, are impaired. We assess the recoverability of assets by comparing the projected undiscounted net cash flows associated with those assets to their respective carrying amounts. We measure any impairment loss by comparing the fair value of the asset to its carrying amount. We estimate fair value based on discounted future cash flows, quoted market prices, or independent appraisals. During the fourth quarter of fiscal year 2023, the Company recorded $85.8 million of acquired intangible asset impairment charges. See Note 7 — Intangibles, net and Goodwill for further detail. There were no other material intangible asset impairments recorded in fiscal years 2023, 2022, and 2021. Foreign Currency Translation Some of the Company's subsidiaries utilize the local currency as the functional currency. The Company’s main entities, including the entities that generate the majority of sales and employ the majority of employees, are U.S. dollar functional. Concentration of Credit Risk Financial instruments that potentially subject us to material concentrations of credit risk consist primarily of cash equivalents, marketable securities, long-term marketable securities, and trade accounts receivable. We are exposed to credit risk to the extent of the amounts recorded on the balance sheet. By policy, our cash equivalents, marketable securities, and long-term marketable securities are subject to certain nationally recognized credit standards, issuer concentrations, sovereign risk, and marketability or liquidity considerations. In evaluating our trade receivables, we perform credit evaluations of our major customers’ financial condition and monitor closely all of our receivables to limit our financial exposure by limiting the length of time and amount of credit extended. In certain situations, we may require payment in advance or utilize letters of credit to reduce credit risk. By policy, we establish a reserve for trade accounts receivable based on the type of business in which a customer is engaged, the length of time a trade account receivable is outstanding, and other knowledge that we may possess relating to the probability that a trade receivable is at risk for non-payment. We had three contract manufacturers aggregated at their parent level, Foxconn, Pegatron and Luxshare Precision, who represented 35 percent, 16 percent, 11 percent, respectively, of our consolidated gross trade accounts receivable as of the end of fiscal year 2023. We had two contract manufacturers aggregated at their parent level, Foxconn and Pegatron, who represented 49 percent and 17 percent, respectively, of our consolidated gross trade accounts receivable as of the end of fiscal year 2022. No other distributor or contract manufacturer had receivable balances that represented more than 10 percent of consolidated gross trade accounts receivable as of the end of fiscal year 2023 or 2022. Since the components we produce are largely proprietary and generally not available from second sources, we consider our end customer to be the entity specifying the use of our component in their design. These end customers may then purchase our products directly from us, from a distributor, or through a third-party manufacturer contracted to produce their end product. For fiscal year 2023, our ten largest end customers represented approximately 92 percent and for each of fiscal years 2022 and 2021, our ten largest end customers represented 93 percent of our sales. For fiscal years 2023, 2022, and 2021, we had one end customer, Apple Inc., who purchased through multiple contract manufacturers and represented approximately 83 percent, 79 percent, and 83 percent, of the Company’s total sales, respectively. No other customer or distributor represented more than 10 percent of net sales in fiscal years 2023, 2022, or 2021. Revenue Recognition We recognize revenue upon the transfer of promised goods or services to customers, in an amount that reflects the consideration the Company expects to be entitled in exchange for those goods or services. Performance Obligations The Company’s single performance obligation is the delivery of promised goods to the customer. The promised goods are explicitly stated in the customer contract and are comprised of a single type of good. This performance obligation is satisfied upon transfer of control of the promised goods to the customer, as defined per the shipping terms within the customer’s contract. The vast majority of the Company’s contracts with customers have an original expected term of one year or less. A s allowed by ASC 606, the Company has not disclosed the value of any unsatisfied performance obligations related to these contracts. Contract balances Payments are typically due within 30 to 60 days of invoicing and terms do not include a significant financing component or noncash consideration. There have been no material impairment losses on accounts receivable. There are no material contract assets or contract liabilities recorded on the consolidated balance sheets. Transaction price The transaction price is the amount of consideration to which the Company expects to be entitled in exchange for transferring the promised goods to the customer. Fixed pricing is the consideration that is agreed upon in the customer contract. Variable pricing includes rights of return, price protection and stock rotation. Rights of return costs are estimated using the "most likely amount" method by reviewing historical returns to determine the most likely customer return rate and applying materiality thresholds. Price protection includes price adjustments available to certain distributors based upon established book price and a stated adjustment period. Stock rotation is also available to certain distributors based on a stated maximum of prior billings. The Company estimates all variable consideration at the most likely amount which it expects to be entitled. The estimate is based on current and historical information available to the Company, including recent sales activity and pricing. Variable consideration is only included in the transaction price to the extent that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved. The Company defers all variable consideration that does not meet the revenue recognition criteria. Shipping Costs Our shipping and handling costs are included in cost of sales for all periods presented in the consolidated statements of income. Advertising Costs Advertising costs are expensed as incurred. Advertising costs were $0.5 million, $0.9 million, and $0.9 million, in fiscal years 2023, 2022, and 2021, respectively. Stock-Based Compensation Stock-based compensation is measured at the grant date based on the grant-date fair value of the awards and is recognized as an expense, on a ratable basis, over the vesting period, which is generally between 1 and 4 years. Determining the amount of stock-based compensation to be recorded requires the Company to develop estimates used in calculating the grant-date fair value of stock options and performance awards (also called market stock units). The Company calculates the grant-date fair value for stock options and market stock units using the Black-Scholes valuation model and the Monte Carlo simulation, respectively. The use of valuation models requires the Company to make estimates of assumptions such as expected volatility, expected term, risk-free interest rate, expected dividend yield, and forfeiture rates. The grant-date fair value of restricted stock units is the market value at grant date multiplied by the number of units. Income Taxes We are required to calculate income taxes in each of the jurisdictions in which we operate. This process involves calculating the actual current tax liability as well as assessing temporary differences in the recognition of income or loss for tax and accounting purposes. These differences result in deferred tax assets and liabilities, which are included in our consolidated balance sheet. We record a valuation allowance when it is more likely than not that some portion or all of the deferred tax assets will not be realized. The Company evaluates the ability to realize its deferred tax assets based on all the facts and circumstances, including projections of future taxable income and expiration dates of carryover tax attributes. The calculation of our tax liabilities involves assessing uncertainties with respect to the application of complex tax rules and the potential for future adjustment of our uncertain tax positions by the U.S. Internal Revenue Service or other taxing jurisdiction. We recognize liabilities for uncertain tax positions based on the required two-step process. The first step requires us to determine if the weight of available evidence indicates that the tax position has met the threshold for recognition; therefore, we must evaluate whether it is more likely than not that the position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step requires us to measure the tax benefit of the tax position taken, or expected to be taken, in an income tax return as the largest amount that is more than 50 percent likely of being realized upon ultimate settlement. We reevaluate the uncertain tax positions each quarter based on factors including, but not limited to, changes in facts or circumstances, changes in tax law, expirations of statutes of limitation, effectively settled issues under audit, and new audit activity. A change in the recognition step or measurement step would result in the recognition of a tax benefit or an additional charge to the tax provision in the period. Although we believe the measurement of our liabilities for uncertain tax positions is reasonable, we cannot assure that the final outcome of these matters will not be different than what is reflected in the historical income tax provisions and accruals. If additional taxes are assessed as a result of an audit or litigation, it could have a material effect on our income tax provision and net income in the period or periods for which that determination is made. We operate within multiple taxing jurisdictions and are subject to audit in these jurisdictions. These audits can involve complex issues which may require an extended period of time to resolve and could result in additional assessments of income tax. We believe adequate provisions for income taxes have been made for all periods. See Note 19 - Income Taxes for further detail. Government Assistance The Company benefits from the Research and Development Expenditure Credit (“RDEC”) program in the United Kingdom. The RDEC is recorded as an offset to research and development expenses in the consolidated statements of income Other current Assets " and " Other assets " on the consolidated balance sheet. While the duration of RDEC benefits is indefinite, the program is subject to future policy changes and RDEC claims are subject to regular audits by the United Kingdom government. Net Income Per Share Basic net income per share is based on the weighted effect of common shares issued and outstanding and is calculated by dividing net income by the basic weighted average shares outstanding during the period. Diluted net income per share is calculated by dividing net income by the weighted average number of common shares used in the basic net income per share calculation, plus the equivalent number of common shares that would be issued assuming exercise or conversion of all potentially dilutive common shares outstanding. These potentially dilutive items consist primarily of outstanding stock options and restricted stock grants. The following table details the calculation of basic and diluted earnings per share for fiscal years 2023, 2022, and 2021, (in thousands, except per share amounts): Fiscal Years Ended March 25, 2023 March 26, 2022 March 27, 2021 Numerator: Net income $ 176,703 $ 326,355 $ 217,344 Denominator: Weighted average shares outstanding 55,614 57,278 58,106 Effect of dilutive securities 1,612 1,865 1,954 Weighted average diluted shares 57,226 59,143 60,060 Basic earnings per share $ 3.18 $ 5.70 $ 3.74 Diluted earnings per share $ 3.09 $ 5.52 $ 3.62 The weighted outstanding shares excluded from our diluted calculation for the years ended March 25, 2023, March 26, 2022, and March 27, 2021 were 268 thousand, 113 thousand, and 187 thousand, respectively, as the exercise price of certain outstanding stock options exceeded the average market price during the period. Accumulated Other Comprehensive Loss Our accumulated other comprehensive loss is comprised of foreign currency translation adjustments and unrealized gains and losses on investments classified as available-for-sale. See Note 18 — Accumulated Other Comprehensive Income (Loss) for additional discussion. Recently Adopted Accounting Pronouncements In November 2021, the FASB issued ASU No. 2021-10, Government Assistance (Topic 832) – Disclosures by Business Entities about Government Assistance, which requires annual disclosures about transactions with a government that are accounted for by applying a grant or contribution type accounting model. The disclosures requires information about the nature and related policy used for the transactions, the line items on the balance sheet and income statement that are affected and the amounts applicable to each financial statement line item, and significant terms and conditions of the transactions. This ASU is effective for financial statements issued for annual periods beginning after December 15, 2021. The Company adopted this ASU in the fourth quarter of fiscal year 2023 on a prospective basis. See related policy discussion above. In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 805) – Accounting for Contract Assets and Contract Liabilities from Contracts with Customers , which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured at the acquisition date in accordance with Revenue from Contracts with Customers (Topic 606) as if the acquirer had originated the contracts . Prior to the issuance of this ASU, contract assets and liabilities were recognized at fair value on the acquisition date. This ASU is effective for fiscal years beginning after December 15, 2022, including interim periods within that fiscal year, with early adoption permitted, and should be applied on a prospective basis. The Company early adopted this ASU in the fourth quarter of fiscal year 2023 with no material impact to the financial statements. |
Marketable Securities
Marketable Securities | 12 Months Ended |
Mar. 25, 2023 | |
Marketable Securities [Abstract] | |
Marketable Securities | Marketable Securities The Company’s investments have been classified as available-for-sale securities in accordance with U.S. GAAP. Marketable securities are categorized on the consolidated balance sheet as “ Marketable securities” within the short-term or long-term classification, as appropriate. The following table is a summary of available-for-sale securities (in thousands): As of March 25, 2023 Amortized Gross Unrealized Gross Unrealized Estimated Fair Value Corporate debt securities $ 66,753 $ 91 $ (1,825) $ 65,019 Non-U.S. government securities 510 — (3) 507 U.S. Treasury securities 5,728 17 (151) 5,594 Agency discount notes 385 — (18) 367 Total securities $ 73,376 $ 108 $ (1,997) $ 71,487 The Company typically invests in highly-rated securities with original maturities generally ranging from one As of March 26, 2022 Amortized Gross Unrealized Gross Unrealized Estimated Fair Value Corporate debt securities $ 70,296 $ 2 $ (2,133) $ 68,165 Non-U.S. government securities 509 — (9) 500 U.S. Treasury securities 5,483 — (169) 5,314 Agency discount notes 385 — (14) 371 Total securities $ 76,673 $ 2 $ (2,325) $ 74,350 The Company’s specifically identified gross unrealized losses of $2.3 million related to securities with total amortized costs of approximately $75.5 million at March 26, 2022. Securities in a continuous unrealized loss position for more than 12 months as of March 26, 2022 had an aggregate amortized cost of $3.5 million and an aggregate unrealized loss of $0.1 million as of March 26, 2022. As of March 26, 2022, the Company did not consider any of its investments to be impaired. The cost and estimated fair value of available-for-sale investments by contractual maturity were as follows: March 25, 2023 March 26, 2022 Amortized Estimated Amortized Estimated Within 1 year $ 35,824 $ 34,978 $ 10,697 $ 10,601 After 1 year 37,552 36,509 65,976 63,749 Total $ 73,376 $ 71,487 $ 76,673 $ 74,350 |
Fair Value of Financial Instrum
Fair Value of Financial Instruments | 12 Months Ended |
Mar. 25, 2023 | |
Fair Value Disclosures [Abstract] | |
Fair Value of Financial Instruments | Fair Value of Financial Instruments The Company has determined that the assets and liabilities in the Company’s financial statements that are required to be measured at fair value on a recurring basis are the Company’s cash equivalents and marketable securities portfolio. The Company defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). ▪ Level 1 — Quoted prices in active markets for identical assets or liabilities. ▪ Level 2 — Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. ▪ Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The Company’s cash equivalents and marketable securities portfolio consist of money market funds, commercial paper, debt securities, non-U.S government securities, U.S Treasury securities, and securities of U.S. government-sponsored enterprises, and are reflected on our consolidated balance sheet under the headings cash and cash equivalents, marketable securities, and long-term marketable securities. The Company determines the fair value of its marketable securities portfolio by obtaining non-binding market prices from its third-party pricing providers on the last day of the quarter, whose sources may use quoted prices in active markets for identical assets (Level 1 inputs) or inputs other than quoted prices that are observable either directly or indirectly (Level 2 inputs) in determining fair value. The Company’s long-term revolving facility, described in Note 9 - Revolving Credit Facility, bears interest at a base rate plus applicable margin or forward-looking secured overnight financing rate ("Term SOFR") plus 10 basis points plus applicable margin. As of March 25, 2023, there are no amounts drawn under the facility and the fair value is zero. As of March 25, 2023 and March 26, 2022, the Company has no material Level 3 assets or liabilities. There were no transfers between Level 1, Level 2, or Level 3 measurements for the years ending March 25, 2023 and March 26, 2022. The following summarizes the fair value of our financial instruments at March 25, 2023 (in thousands): Quoted Prices Significant Significant Total Assets: Cash equivalents Money market funds $ 406,265 $ — $ — $ 406,265 Available-for-sale securities Corporate debt securities $ — $ 65,019 $ — $ 65,019 Non-U.S. government securities — 507 — 507 U.S. Treasury securities 5,594 — — 5,594 Agency discount notes — 367 — 367 $ 5,594 $ 65,893 $ — $ 71,487 The following summarizes the fair value of our financial instruments at March 26, 2022 (in thousands): Quoted Prices Significant Significant Total Assets: Cash equivalents Money market funds $ 217,151 $ — $ — $ 217,151 Commercial paper — 249 — 249 $ 217,151 $ 249 $ — $ 217,400 Available-for-sale securities Corporate debt securities $ — $ 68,165 $ — $ 68,165 Non-U.S. government securities — 500 — 500 U.S. Treasury securities 5,314 — — 5,314 Agency discount notes — 371 — 371 $ 5,314 $ 69,036 $ — $ 74,350 |
Derivative Financial Instrument
Derivative Financial Instruments | 12 Months Ended |
Mar. 25, 2023 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Derivative Financial Instruments | Derivative Financial Instruments Foreign Currency Forward Contracts The Company uses foreign currency forward contracts to reduce the earnings impact that exchange rate fluctuations have on non-functional currency balance sheet exposures. The Company recognizes both the gains and losses on foreign currency forward contracts and the gains and losses on the remeasurement of non-functional currency assets and liabilities within "Other income (expense)" in the consolidated statements of income. The Company does not apply hedge accounting to these foreign currency derivative instruments. As of March 25, 2023, the Company held one foreign currency forward contract denominated in British Pound Sterling with a notional value of $7.6 million. The fair value of this contract was not material as of March 25, 2023. The before-tax effect of derivative instruments not designated as hedging instruments was as follows (in thousands): Fiscal Years Ended March 25, 2023 March 26, 2022 March 27, 2021 Location Gain (loss) recognized in income Foreign currency forward contracts $ (564) $ (283) $ 3,212 Other income (expense) |
Accounts Receivable, net
Accounts Receivable, net | 12 Months Ended |
Mar. 25, 2023 | |
Accounts Receivable, after Allowance for Credit Loss [Abstract] | |
Accounts Receivable, net | Accounts Receivable, net The following are the components of accounts receivable, net (in thousands): March 25, 2023 March 26, 2022 Gross accounts receivable $ 150,473 $ 240,264 Allowance for doubtful accounts — — Accounts receivable, net $ 150,473 $ 240,264 The Company regularly evaluates the collectability of accounts receivable based on age, historical customer payment trends and ongoing customer relations. The allowance for doubtful accounts and recoveries on bad debt were immaterial for fiscal years 2023, 2022, and 2021. The significant decrease in accounts receivable is due primarily to the volume and timing of shipments in the current fiscal quarter versus the fourth quarter of fiscal year 2022. |
Intangibles, net and Goodwill
Intangibles, net and Goodwill | 12 Months Ended |
Mar. 25, 2023 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Intangibles, net and Goodwill | Intangibles, net and Goodwill In the fourth quarter of fiscal 2023, due to the prolonged weakness in the China smartphone market, which has had an adverse effect on sales of our general market battery and power products associated with the acquisition of Lion Semiconductor, Inc. ("Lion") (the "Acquisition"), the Company was prompted to assess the recoverability and fair value of the acquired intangible assets recorded in purchase accounting. The Company determined that a replacement cost approach was the most appropriate method to evaluate remaining fair value of the technology. As a result, the Company recorded an intangibles impairment charge of $85.8 million in fiscal year 2023. The following information details the gross carrying amount, accumulated amortization, and net carrying value of our intangible assets subject to amortization (in thousands): March 25, 2023 March 26, 2022 Intangible Category / Gross Accumulated Net Carrying Value Gross Accumulated Net Carrying Value Existing technology (5.3) 146,146 (110,792) 35,354 255,995 (124,127) 131,868 In-process research & development (a) 70,936 (70,936) — 70,936 (67,486) 3,450 Trademarks and tradename (0.5) 3,037 (2,973) 64 3,037 (2,845) 192 Customer relationships (1.4) 15,381 (13,422) 1,959 34,091 (14,379) 19,712 Technology licenses (1.7) 23,490 (21,991) 1,499 22,376 (19,453) 2,923 Total $ 258,990 $ (220,114) $ 38,876 $ 386,435 $ (228,290) $ 158,145 (a) Intangible assets are fully amortized as of March 25, 2023. Amortization expense for intangibles in fiscal years 2023, 2022, and 2021 was $33.7 million, $29.0 million, and $14.5 million, respectively. The following table details the estimated aggregate amortization expense for all intangibles owned as of March 25, 2023, for each of the five succeeding fiscal years and in the aggregate thereafter (in thousands): Fiscal Year 2024 $ 9,221 2025 $ 7,600 2026 $ 6,681 2027 $ 6,589 2028 $ 6,589 Thereafter $ 2,196 The goodwill balance included on the consolidated balance sheet was $435.9 million and $435.8 million at March 25, 2023 and March 26, 2022, respectively. |
Acquisition
Acquisition | 12 Months Ended |
Mar. 25, 2023 | |
Business Combination and Asset Acquisition [Abstract] | |
Acquisition | Acquisition There were no acquisitions completed during fiscal year 2023. During fiscal year 2022, the Company completed the acquisition of Lion. As a result of acquiring 100 percent of the outstanding share capital of Lion, Lion became a wholly-owned subsidiary of the Company. This transaction was accounted for as a business combination using the acquisition method of accounting. All of the acquired assets and liabilities of Lion have been recorded at their respective fair values as of the acquisition date. At the acquisition date, total consideration transferred was approximately $280.5 million, inclusive of $4.9 million in cash acquired. During the third quarter of fiscal year 2022, an additional $1.2 million of consideration was paid related to contractual post-closing adjustment provisions. The remaining merger consideration of $31.0 million was subject to indemnity provisions as outlined in the merger agreement and paid during fiscal year 2023. In addition, $25.4 million of the merger consideration relates to retention agreements with certain key employees that are subject to continued employment with the Company. The merger consideration subject to retention agreements is treated as compensation expense and is recognized over the retention period in " Research and development" expense in the consolidated statements of income. The excess of the purchase price over the net assets acquired was recorded as goodwill during fiscal year 2022. |
Revolving Credit Facility
Revolving Credit Facility | 12 Months Ended |
Mar. 25, 2023 | |
Debt Disclosure [Abstract] | |
Revolving Credit Facility | Revolving Credit Facility On July 8, 2021, the Company entered into a second amended and restated credit agreement (the “Second Amended Credit Agreement”) with Wells Fargo Bank, National Association, as administrative agent, and the lenders party thereto. The Second Amended Credit Agreement provides for a $300 million senior secured revolving credit facility (the “Revolving Credit Facility”). The Revolving Credit Facility matures on July 8, 2026 (the “Maturity Date”). The Revolving Credit Facility is required to be guaranteed by all of Cirrus Logic’s material domestic subsidiaries (the "Subsidiary Guarantors"). The Revolving Credit Facility is secured by substantially all the assets of Cirrus Logic and any Subsidiary Guarantors, except for certain excluded assets. On March 20, 2023, the Company, entered into the First Amendment (the "Amendment") to its Second Amended Credit Agreement, with the lending institutions party thereto and Wells Fargo Bank, National Association, as administrative agent. The Amendment updates the benchmark interest rate provisions to replace the London interbank offered rate ("LIBOR") with the forward-looking secured overnight financing rate ("Term SOFR"), for the purposes of calculating interest under the terms of the Second Amended Credit Agreement. Borrowings under the Revolving Credit Facility may, at Cirrus Logic’s election, bear interest at either (a) a base rate plus the applicable margin ("Base Rate Loans") or (b) a Term SOFR rate plus a 10 basis point credit spread adjustment plus the applicable margin. The applicable margin ranges from 0% to 0.75% per annum for Base Rate Loans and 1.00% to 1.75% per annum for SOFR Loans based on the ratio of consolidated funded indebtedness to consolidated EBITDA for the most recently ended period of four consecutive fiscal quarters (the “Consolidated Leverage Ratio”). A Commitment Fee accrues at a rate per annum ranging from 0.175% to 0.275% (based on the Consolidated Leverage Ratio) on the average daily unused portion of the commitment of the lenders. The Revolving Credit Facility contains certain financial covenants providing that (a) the ratio of consolidated funded indebtedness (minus up to $200 million of unrestricted cash and cash equivalents available on such date) to consolidated EBITDA for the prior four consecutive quarters must not be greater than 3.00 to 1.00 (the “Consolidated Net Leverage Ratio”) and (b) the ratio of consolidated EBITDA for the prior four consecutive quarters to consolidated interest expense paid or payable in cash for the prior four consecutive quarters must not be less than 3.00 to 1.00 (the “Consolidated Interest Coverage Ratio”). The Second Amended Credit Agreement also contains negative covenants limiting the Company's or any Subsidiary's ability to, among other things, incur debt, grant liens, make investments, effect certain fundamental changes, make certain asset dispositions, and make certain restricted payments. Further, the Second Amended Credit Agreement contains customary affirmative covenants, including, among others, covenants regarding the payment of taxes and other obligations, maintenance of insurance, reporting requirements, and compliance with applicable laws and regulations. As of March 25, 2023, the Company had no amounts outstanding under the Revolving Credit Facility and was in compliance with all covenants under the Second Amended Credit Agreement. As of March 25, 2023, future interest payment obligations based on forecasted commitment fees under the Revolving Credit Facility were as follows (in thousands): Fiscal Year 2024 $ 528 2025 534 2026 532 2027 277 2028 — Thereafter — Total $ 1,871 |
Revenues
Revenues | 12 Months Ended |
Mar. 25, 2023 | |
Revenue from Contract with Customer [Abstract] | |
Revenues | Revenues Disaggregation of revenue We disaggregate revenue from contracts with customers by product line and ship to location of the customer. Sales are designated in the product line categories of Audio and High-Performance Mixed-Signal ("HPMS"). Total net sales based on the product line disaggregation criteria described above are shown in the table below (in thousands). Fiscal Years Ended March 25, 2023 March 26, 2022 March 27, 2021 Audio Products $ 1,172,007 $ 1,187,126 $ 1,104,060 HPMS Products 725,610 594,334 265,170 Total $ 1,897,617 $ 1,781,460 $ 1,369,230 The geographic regions that are reviewed are China, the United States, and the rest of the world. Total net sales based on the geographic disaggregation criteria described are as follows (in thousands): Fiscal Years Ended March 25, March 26, March 27, 2023 2022 2021 China $ 1,230,602 $ 1,197,812 $ 1,024,178 United States 52,688 29,513 21,708 Rest of World 614,327 554,135 323,344 Total $ 1,897,617 $ 1,781,460 $ 1,369,230 See Note 2 - Summary of Significant Accounting Policies for additional discussion surrounding revenue recognition considerations. |
Leases
Leases | 12 Months Ended |
Mar. 25, 2023 | |
Leases [Abstract] | |
Leases | Leases The Company has operating leases for corporate offices and certain office equipment. Our leases have remaining lease terms of 1 year to 26 years, some of which include options to extend the leases that are considered reasonably certain to be exercised. There are no residual value guarantees in any of our leases. No restrictions or covenants have been imposed on the Company as a result of the lease agreements in place. All of the Company’s leases have been classified as operating leases. The components of net operating lease expense were as follows (in thousands): Fiscal Years Ended March 25, 2023 March 26, 2022 Operating lease - in excess of 12 months $ 18,071 $ 14,901 Variable lease 6,226 4,954 Short-term lease 86 22 Operating lease income (464) (1,518) Total net operating lease expense $ 23,919 $ 18,359 Supplemental operating lease information: Fiscal Years Ended March 25, 2023 March 26, 2022 Balance Sheet Information (in thousands) Operating lease right-of-use assets $ 128,145 $ 171,003 Operating lease liabilities $ 141,073 $ 177,842 Cash Flow Information (in thousands) Operating cash flows from operating leases $ 14,531 $ 14,634 Non-Cash Information Right-of-use assets obtained in exchange for new operating lease liabilities 4,381 46,123 Lease remeasurements (28,965) — Lease impairments (5,579) — Operating Lease Information Weighted-average remaining lease term - operating leases (in years) 13 16 Weighted-average discount rate - operating leases 4 % 4 % As of March 25, 2023, we have an additional operating lease, that has not yet commenced, with estimated lease obligations of approximately $24 million. This operating lease will commence in fiscal year 2024 with a lease term of approximately 10 years. Future lease commitments under non-cancellable leases, including extension options reasonably anticipated to be exercised as of March 25, 2023, are as follows (in thousands): Fiscal Year Operating Lease Expense 2024 $ 18,631 2025 19,598 2026 18,043 2027 16,489 2028 16,882 Thereafter 106,651 Total $ 196,294 Less imputed interest and other (55,221) Total $ 141,073 Operating lease liabilities consisted of the following (in thousands): March 25, 2023 March 26, 2022 Current lease liabilities $ 18,442 $ 14,680 Non-current lease liabilities 122,631 163,162 Total operating lease liabilities $ 141,073 $ 177,842 |
Lease Impairments and Restructu
Lease Impairments and Restructuring | 12 Months Ended |
Mar. 25, 2023 | |
Restructuring and Related Activities [Abstract] | |
Lease Impairments and Restructuring | Lease Impairments and Restructuring During the year ended March 25, 2023, the Company was focused on improving operational efficiency and accordingly took a number of steps, including reducing our global real estate footprint, product prioritization, and some restructuring actions. In the fourth quarter of fiscal year 2023, as part of this strategy, the Company decided to abandon or sublease office space at various properties worldwide to align our real property lease arrangements with our anticipated operating needs. As a result, the Company recorded $10.6 million of lease impairments and restructuring charges which consisted of $6.9 million of impairment of right-of-use lease assets and leasehold improvements, and $3.7 million of other related charges in the fourth quarter of fiscal 2023. Restructuring-related liabilities of $3.3 million are primarily presented within the " Other accrued liabilities " on the consolidated balance sheet. We expect the restructuring related liabilities to be substantially paid out in cash during fiscal year 2024. |
Postretirement Benefit Plans
Postretirement Benefit Plans | 12 Months Ended |
Mar. 25, 2023 | |
Retirement Benefits [Abstract] | |
Postretirement Benefit Plans | Postretirement Benefit PlansWe have Defined Contribution Plans (“the Plans”) covering all of our qualifying employees. Under the Plans, employees may elect to contribute any percentage of their annual compensation up to the annual regulatory limits. The Company made matching employee contributions of $10.2 million, $9.6 million, and $7.9 million during fiscal years 2023, 2022, and 2021, respectively. |
Equity Compensation
Equity Compensation | 12 Months Ended |
Mar. 25, 2023 | |
Share-Based Payment Arrangement, Noncash Expense [Abstract] | |
Equity Compensation | Equity CompensationThe Company is currently granting equity awards from the 2018 Long Term Incentive Plan (the “Plan”), which was approved by stockholders in August 2018 and subsequently amended on July 29, 2022. The Plan provides for granting of stock options, restricted stock awards, performance awards, phantom stock awards, and bonus stock awards, or any combination of the foregoing. To date, the Company has granted stock options, restricted stock awards, phantom stock awards (also called restricted stock units), and performance awards (also called market stock units). Each stock option granted reduces the total shares available for grant under the Plan by one share. Each full value award granted (including restricted stock awards, restricted stock units and market stock units) reduces the total shares available for grant under the Plan by 1.5 shares. Stock options generally vest between one Restricted stock units are generally subject to vesting from one The following table summarizes the activity in total shares available for grant (in thousands): Shares Available for Grant Balance, March 28, 2020 2,095 Shares added 3,223 Granted (1,491) Forfeited 198 Balance, March 27, 2021 4,025 Shares added — Granted (1,679) Forfeited 271 Balance, March 26, 2022 2,617 Shares added 2,090 Granted (2,536) Forfeited 303 Balance, March 25, 2023 2,474 Stock-based Compensation Expense The following table summarizes the effects of stock-based compensation on cost of goods sold, research and development, sales, general and administrative, pre-tax income, and net income after taxes for shares granted under the Plan (in thousands, except per share amounts): Fiscal Year 2023 2022 2021 Cost of sales $ 1,270 $ 1,024 $ 900 Research and development 57,312 44,154 37,483 Sales, general and administrative 23,059 21,214 18,379 Effect on pre-tax income 81,641 66,392 56,762 Income Tax Benefit (15,184) (11,521) (9,558) Total stock-based compensation expense (net of taxes) 66,457 54,871 47,204 Stock-based compensation effects on basic earnings per share $ 1.19 $ 0.96 $ 0.81 Stock-based compensation effects on diluted earnings per share 1.16 0.93 0.79 The total stock-based compensation expense included in the table above and which is attributable to restricted stock units and market stock units was $78.0 million, $63.2 million, $53.6 million, for fiscal years 2023, 2022, and 2021, respectively. Stock-based compensation expense is presented within operating activities in the consolidated statement of cash flows. As of March 25, 2023, there was $155.3 million of compensation costs related to non-vested stock options, restricted stock units, and market stock units granted under the Company’s equity incentive plans not yet recognized in the Company’s financial statements. The unrecognized compensation cost is expected to be recognized over a weighted average period of 1.61 years for stock options, 1.62 years for restricted stock units, and 2.02 years for market stock units. In addition to the income tax benefit of stock-based compensation expense shown in the tabl e above, the Company recognized excess tax benefits of $1.4 million, $3.9 million and $2.2 million in fiscal years 2023, 2022, and 2021 respectively. Stock Options We estimate the fair value of each stock option on the date of grant using the Black-Scholes option-pricing model using a dividend yield of zero and the following additional assumptions: March 25, 2023 March 26, 2022 March 27, 2021 Expected stock price volatility 35.18% - 46.50% 36.85% - 41.66% 43.85% - 43.99% Risk-free interest rate 2.47% - 3.96% 0.82% - 1.62% 0.35% - 0.72% Expected term (in years) 4.04 - 4.33 4.22 - 4.39 4.32 - 4.43 The Black-Scholes valuation calculation requires us to estimate key assumptions such as stock price volatility, expected term, risk-free interest rate and dividend yield. The expected stock price volatility is based upon implied volatility from traded options on our stock in the marketplace. The expected term of options granted is derived from an analysis of historical exercises and remaining contractual life of stock options, and represents the period of time that options granted are expected to be outstanding after becoming vested. The risk-free interest rate reflects the yield on zero-coupon U.S. Treasury securities for a period that is commensurate with the expected term assumption. Finally, we have never paid cash dividends, do not currently intend to pay cash dividends, and thus have assumed a zero percent dividend yield. Using the Black-Scholes option valuation model, the weighted average estimated fair values of employee stock options granted in fiscal years 2023, 2022, and 2021, were $42.37, $37.31, and $33.81, respectively. During fiscal years 2023, 2022, and 2021, we received a net $10.1 million, $13.2 million, and $7.1 million, respectively, from the exercise of 0.2 million, 0.3 million, and 0.2 million, respectively, stock options granted under the Company’s Stock Plan. The total intrinsic value of stock options exercised during fiscal year 2023, 2022, and 2021, was $11.4 million, $15.8 million, and $10.2 million, respectively. Intrinsic value represents the difference between the market value of the Company’s common stock at the time of exercise and the strike price of the stock option. Additional information with respect to stock option activity is as follows (in thousands, except per share amounts): Outstanding Options Number Weighted Balance, March 28, 2020 1,216 $ 44.01 Options granted 96 77.23 Options exercised (236) 30.26 Options forfeited (17) 56.27 Options expired — — Balance, March 27, 2021 1,059 $ 49.87 Options granted 88 87.52 Options exercised (327) 40.31 Options forfeited — — Options expired — — Balance, March 26, 2022 820 $ 57.75 Options granted 143 96.33 Options exercised (225) 45.10 Options forfeited (18) 71.14 Options expired — — Balance, March 25, 2023 720 $ 69.03 Additional information with regards to outstanding options that are vesting, expected to vest, or exercisable as of March 25, 2023 is as follows (in thousands, except years and per share amounts): Number of Weighted Weighted Average Aggregate Vested and expected to vest 709 $ 68.63 6.67 $ 26,208 Exercisable 452 $ 57.01 5.37 $ 21,955 In accordance with U.S. GAAP, stock options outstanding that are expected to vest are presented net of estimated future option forfeitures, which are estimated as compensation costs are recognized. Options with a fair value of $3.0 million, $4.6 million, and $4.8 million, became vested during fiscal years 2023, 2022, and 2021, respectively. The following table summarizes information regarding outstanding and exercisable options as of March 25, 2023 (in thousands, except per share amounts): Options Outstanding Options Exercisable Weighted Average Weighted Number Weighted Range of Exercise Prices Number (years) Price Exercisable Exercise Price $20.37 - $54.65 200 4.30 $ 45.06 200 $ 45.06 $55.72 - $68.56 215 5.70 62.55 193 61.83 $78 - $82.14 100 8.20 78.53 39 78.27 $82.81 - $82.81 21 9.11 82.81 — — $88 - $88 81 8.94 88.00 20 88.00 $102.37 - $102.37 103 9.87 102.37 — — 720 6.71 $ 69.03 452 $ 57.01 As of March 25, 2023, March 26, 2022, and March 27, 2021, the number of options exercisable was 0.5 million, 0.6 million, and 0.7 million respectively. Restricted Stock Units Restricted stock units (“RSUs”) are valued as of the grant date and amortized over the requisite vesting period. Generally, RSUs vest 100 percent on the first to third anniversary of the grant date depending on the vesting specifications. A summary of the activity for RSUs in fiscal year 2023, 2022, and 2021 is presented below (in thousands, except per share amounts): Shares Weighted March 28, 2020 2,680 $ 53.74 Granted 945 71.44 Vested (881) 52.97 Forfeited (131) 55.36 March 27, 2021 2,613 $ 60.31 Granted 1,079 81.61 Vested (935) 43.96 Forfeited (181) 70.60 March 26, 2022 2,576 $ 74.45 Granted 1,574 75.97 Vested (877) 70.02 Forfeited (183) 75.58 March 25, 2023 3,090 $ 76.42 The aggregate intrinsic value of RSUs outstanding as of March 25, 2023, March 26, 2022, and March 27, 2021 was $326.3 million, $225.9 million, and $216.9 million, respectively. Additional information with regards to outstanding RSUs that are expected to vest as of March 25, 2023, is as follows (in thousands, except year and per share amounts): Shares Weighted Weighted Average Expected to vest 2,896 $ 76.42 1.60 RSUs outstanding that are expected to vest are presented net of estimated future forfeitures, which are estimated as compensation costs are recognized. RSUs with a fair value of $61.4 million, $41.1 million, and $46.7 million became vested during fiscal years 2023, 2022, and 2021, respectively. The majority of RSUs that vested in 2023, 2022 and 2021 were net settled such that the Company withheld a portion of the shares to satisfy tax withholding requirements. In fiscal years 2023, 2022, and 2021 the vesting of RSUs reduced the authorized and unissued share balance by approximately 0.9 million, 0.9 million, and 0.9 million, respectively. Total shares withheld and subsequently retired out of the Plan were approximately 0.2 million, 0.3 million, and 0.3 million and total payments for the employees’ tax obligations to taxing authorities were $18.0 million, $22.0 million, and $18.4 million for fiscal years 2023, 2022, and 2021, respectively. Market Stock Units Market stock units (“MSUs”) vest based upon the relative total shareholder return (“TSR”) of the Company as compared to that of the Philadelphia Semiconductor Index (“the Index”). The requisite service period for these MSUs is also the vesting period, which is three years. The fair value of each MSU granted was determined on the date of grant using the Monte Carlo simulation, which calculates the present value of the potential outcomes of future stock prices of the Company and the Index over the requisite service period. The fair value is based on the risk-free rate of return, the volatilities of the stock price of the Company and the Index, the correlation of the stock price of the Company with the Index, and the dividend yield. The fair values estimated from the Monte Carlo simulation were calculated using a dividend yield of zero and the following additional assumptions: Fiscal Years Ended March 25, March 26, March 27, Expected stock price volatility 35.18% - 46.50% 41.66 % 43.85 % Risk-free interest rate 2.67% - 3.92% 1.46 % 0.29 % Expected term (in years) 3.00 3.00 3.00 Using the Monte Carlo simulation, the weighted average estimated fair value of the MSUs granted in fiscal year 2023 was $135.87. A summary of the activity for MSUs in fiscal year 2023, 2022, and 2021 is presented below (in thousands, except per share amounts): Shares Weighted March 28, 2020 153 $ 68.71 Granted 28 83.96 Vested — — Forfeited (48) 64.92 March 27, 2021 133 $ 73.29 Granted 28 109.18 Vested (30) 50.11 Forfeited (46) 38.70 March 26, 2022 85 $ 95.75 Granted 38 135.87 Vested (10) 87.43 Forfeited (24) 94.80 March 25, 2023 89 $ 113.83 The aggregate intrinsic value of MSUs outstanding as of March 25, 2023, March 26, 2022, and March 27, 2021 was $9.3 million, $7.5 million, and $11.0 million, respectively. Additional information with regard to outstanding MSUs that are expected to vest as of March 25, 2023 is as follows (in thousands, except year and per share amounts): Shares Weighted Weighted Average Expected to vest 82 $ 113.13 2.00 |
Commitments and Contingencies
Commitments and Contingencies | 12 Months Ended |
Mar. 25, 2023 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies Facilities and Equipment Under Operating Lease Agreements We currently own our corporate headquarters and select surrounding properties. We lease certain of our other facilities and certain equipment under operating lease agreements, some of which have renewal options. Certain of these arrangements provide for lease payment increases based upon future fair market rates. As of March 25, 2023, our principal facilities are located in Austin, Texas and Edinburgh, Scotland, United Kingdom. Total rent expense under operating leases was approximately $24.4 million, $19.9 million, and $19.2 million, for fiscal years 2023, 2022, and 2021, respectively. Rental income was $0.5 million, $1.5 million, and $1.4 million, for fiscal years 2023, 2022, and 2021, respectively. See Note 11 - Leases for minimum future rental commitments and income under all operating leases as of March 25, 2023. Capacity Reservation Agreement On July 28, 2021, the Company entered into a Capacity Reservation and Wafer Supply Commitment Agreement (the “Capacity Reservation Agreement”) with GLOBALFOUNDRIES Singapore Pte. Ltd. (“GlobalFoundries”) to provide the Company a wafer capacity commitment and wafer pricing for Company products for calendar years 2022-2026 (the “Commitment Period”). The Capacity Reservation Agreement requires GlobalFoundries to provide, and the Company to purchase, a defined number of wafers on a quarterly basis for the Commitment Period, subject to shortfall payments. In exchange for GlobalFoundries’ capacity commitment, the Company paid a $60 million non-refundable capacity reservation fee, which is amortized over the Commitment Period. This reservation fee is recorded in " Other current assets " and " Other assets " on the consolidated balance sheets within the short-term or long-term classification, as appropriate. In addition, the Company pre-paid GlobalFoundries $195 million for future wafer purchases, which will be credited back to the Company as a portion of the price of wafers purchased beginning in the third quarter of calendar year 2023. This prepayment is currently recorded in " Prepaid wafers " and " Long-term prepaid wafers " on the consolidated balance sheets. As of March 25, 2023, the Company estimates its remaining purchase obligation to be approximately $1.2 billion of wafers from GlobalFoundries under the Capacity Reservation Agreement. Purchase Commitments We rely primarily on third-party foundries for our wafer manufacturing needs. With the exception of the terms of the Capacity Reservation Agreement described above, generally, our foundry agreements do not have volume purchase commitments and primarily provide for purchase commitments based on purchase orders. Cancellation fees or other charges may apply and are generally dependent upon whether wafers have been started or the stage of the manufacturing process at which the notice of cancellation is given. In addition to our wafer supply arrangements, we contract with third-party assembly vendors to package the wafer die into finished products. Assembly and test vendors provide fixed-cost-per-unit pricing, as is common in the semiconductor industry. The Company's purchase commitments primarily include the Company's obligations to purchase wafers and related assembly and testing services described above, in addition to future payments related to multi-year tool commitments. Total future unconditional purchase commitments as of March 25, 2023 were as follows (in thousands): Fiscal Year 2024 $ 563,177 2025 379,973 2026 255,222 2027 164,425 2028 2,658 Thereafter — Total $ 1,365,455 |
Legal Matters
Legal Matters | 12 Months Ended |
Mar. 25, 2023 | |
Loss Contingency, Information about Litigation Matters [Abstract] | |
Legal Matters | Legal MattersFrom time to time, we are involved in legal proceedings concerning matters arising in connection with the conduct of our business activities. We regularly evaluate the status of legal proceedings in which we are involved to assess whether a loss is probable or there is a reasonable possibility that a loss or additional loss may have been incurred and to determine if accruals are appropriate. We further evaluate each legal proceeding to assess whether an estimate of possible loss or range of loss can be made. Based on current knowledge, management does not believe that there are any pending matters that could potentially have a material adverse effect on our business, financial condition, results of operations or cash flows. |
Stockholders' Equity
Stockholders' Equity | 12 Months Ended |
Mar. 25, 2023 | |
Stockholders' Equity Note [Abstract] | |
Stockholders' Equity | Stockholders' Equity Share Repurchase Program In January 2021, the Board of Directors authorized the repurchase of up to an additional $350 million of the Company’s common stock. Since inception, a pproximately $348.9 million of the Company’s common stock has been repurchased under the 2021 share repurchase authorization, leaving approximately $1.1 million available for repurchase under this authorization as of March 25, 2023. During the fiscal year ended March 25, 2023, the Company repurchased 2.4 million shares of its common stock for $191.4 million, at an average cost of $81.16 per share. All of these shares were repurchased in the open market and were funded from existing cash. All shares of our common stock that were repurchased were retired as of March 25, 2023. Additionally, in July 2022, the Company announced that the Board of Directors authorized the repurchase of up to an additional $500 million of the Company's common stock. No shares have been repurchased under the 2022 authorization as of March 25, 2023. On August 16, 2022, the U.S. government enacted the Inflation Reduction Act, which, among other things, implemented a 1 percent excise tax on net stock repurchases. Based on our analysis of this provision, we do not believe that this legislation will have a material impact on our financial statements. Preferred Stock We have 5.0 million shares of Preferred Stock authorized. As of March 25, 2023, we have not issued any of the authorized shares. |
Accumulated Other Comprehensive
Accumulated Other Comprehensive Income (Loss) | 12 Months Ended |
Mar. 25, 2023 | |
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] | |
Accumulated Other Comprehensive Income (Loss) | Accumulated Other Comprehensive Income (Loss) Our accumulated other comprehensive income (loss) is comprised of foreign currency translation adjustments, unrealized gains and losses on investments classified as available-for-sale, and cumulative effects of adopting new accounting standards. The following table summarizes the changes in the components of accumulated other comprehensive income (loss), net of tax (in thousands): Foreign Unrealized Gains Cumulative Effect of Adoption of ASU 2018-02 Total Balance, March 27, 2021 $ 294 $ 2,838 $ (257) $ 2,875 Current period foreign exchange translation (507) — — (507) Current period marketable securities activity — (5,587) — (5,587) Tax effect — 1,174 — 1,174 Balance, March 26, 2022 $ (213) $ (1,575) $ (257) $ (2,045) Current period foreign exchange translation (834) — — (834) Current period marketable securities activity — 430 — 430 Tax effect — (90) — (90) Balance, March 25, 2023 $ (1,047) $ (1,235) $ (257) $ (2,539) |
Income Taxes
Income Taxes | 12 Months Ended |
Mar. 25, 2023 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes Income (loss) before income taxes consisted of (in thousands): Fiscal Years Ended March 25, March 26, March 27, U.S. $ (141,670) $ (17,674) $ 19,189 Non-U.S. 396,409 386,337 226,057 $ 254,739 $ 368,663 $ 245,246 The provision (benefit) for income taxes consists of (in thousands): Fiscal Years Ended March 25, March 26, March 27, Current: U.S. $ 60,603 $ 4,483 $ 981 Non-U.S. 52,023 52,920 32,428 Total current tax provision $ 112,626 $ 57,403 $ 33,409 Deferred: U.S. (28,529) (6,256) (192) Non-U.S. (6,061) (8,839) (5,315) Total deferred tax provision (34,590) (15,095) (5,507) Total tax provision $ 78,036 $ 42,308 $ 27,902 The effective income tax rates differ from the rates computed by applying the statutory federal rate to pretax income as follows (in percentages): Fiscal Years Ended March 25, March 26, March 27, U.S. federal statutory rate 21.0 21.0 21.0 Foreign income taxed at different rates (14.4) (9.6) (8.4) Stock-based compensation (0.3) (0.9) (0.8) Foreign-derived intangible income deduction — (0.1) (0.3) GILTI and Subpart F income 30.6 10.0 7.8 Foreign tax credits (7.7) (9.4) (7.4) Change in valuation allowance 0.2 (0.2) — Release of prior year unrecognized tax benefits — — (1.4) Interest related to unrecognized tax benefits 0.7 0.2 0.3 Other 0.5 0.5 0.6 Effective tax rate 30.6 11.5 11.4 The legislation commonly referred to as the Tax Cuts and Jobs Act ("Tax Act") was enacted on December 22, 2017. Under the Tax Act, research and development expenses incurred for tax years beginning after December 31, 2021 must be capitalized and amortized over five or fifteen years for tax purposes, depending on where the research activities are conducted. The Company has elected to treat global intangible low-taxed income ("GILTI") as a period cost, so the capitalization of research and development costs in GILTI increased the Company's provision for income taxes beginning in fiscal year 2023. The Tax Act also required companies to pay a one-time transition tax on earnings of certain foreign subsidiaries that were previously tax-deferred. We elected to pay the transition tax over the eight-year period provided in the Tax Act. As of March 25, 2023, the remaining balance of our transition tax obligation was $25.7 million, which will be paid over the next three years. On August 16, 2022, the U.S. enacted the Inflation Reduction Act, which, among other things, implemented a 15 percent minimum tax on book income of certain large corporations and several tax incentives to promote clean energy. Based on our current analysis of these provisions, this legislation will not have a material impact on our financial statements. Significant components of our deferred tax assets and liabilities as of March 25, 2023 and March 26, 2022 are (in thousands): March 25, March 26, Deferred tax assets: Accrued expenses and allowances $ 7,913 $ 6,517 Net operating loss carryforwards 1,132 1,713 Research and development tax credit carryforwards 13,283 15,230 Stock-based compensation 24,842 18,952 Lease liabilities 21,602 26,653 Capitalized research and development 9,183 6,372 Other 1,119 651 Total deferred tax assets $ 79,074 $ 76,088 Valuation allowance for deferred tax assets (13,076) (13,088) Net deferred tax assets $ 65,998 $ 63,000 Deferred tax liabilities: Depreciation and amortization $ 3,395 $ 3,574 Right of use asset 19,226 25,744 Acquisition intangibles 7,782 32,315 Other 37 — Total deferred tax liabilities $ 30,440 $ 61,633 Total net deferred tax assets $ 35,558 $ 1,367 Deferred tax assets and liabilities are recorded for the estimated tax impact of temporary differences between the tax basis and book basis of assets and liabilities. A valuation allowance is established against a deferred tax asset when it is more likely than not that the deferred tax asset will not be realized. The Company maintains a valuation allowance for certain deferred tax assets primarily relating to certain state net operating loss and state tax credit carryforwards due to the likelihood that they will expire or go unutilized. Our valuation allowance increased by $0.1 million in fiscal year 2023. Management believes that the Company’s results from future operations will generate sufficient taxable income in the appropriate jurisdictions and of the appropriate character such that it is more likely than not that the remaining deferred tax assets will be realized. At March 25, 2023, the Company had gross federal net operating loss carryforwards of $3.0 million, all of which related to acquired companies and are, therefore, subject to certain limitations under Section 382 of the Internal Revenue Code. The federal net operating loss carryforwards expire in fiscal years 2024 through 2031. At March 25, 2023 the Company had gross foreign net operating loss carryforwards of $0.1 million that do not expire and gross state net operating loss carryforwards of $7.5 million that expire in fiscal years 2024 through 2030. In addition, the Company had $13.4 million of state business tax, minimum tax, and research and development tax credit carryforwards. Certain of these state tax credits will expire in fiscal years 2024 through 2034, and others do not expire. At March 25, 2023, unremitted earnings of our foreign subsidiaries that can be distributed without tax consequence, other than withholding taxes that may apply based on the jurisdiction of the subsidiary, are not expected to be indefinitely reinvested. No taxes have been accrued for foreign withholding taxes on these earnings as these amounts are not material. We have not provided additional income taxes for other outside basis differences inherent in our foreign entities, as these amounts continue to be indefinitely reinvested in foreign operations. Determining the amount of unrecognized deferred tax liability related to all other outside basis differences in these entities is not practicable at this time. On July 27, 2015, the U.S. Tax Court issued an opinion in Altera Corp. et al. v. Commissioner which concluded that the regulations relating to the treatment of stock-based compensation expense in intercompany cost-sharing arrangements were invalid. In 2016 the U.S. Internal Revenue Service appealed the decision to the U.S. Court of Appeals for the Ninth Circuit (the “Ninth Circuit”). On July 24, 2018, the Ninth Circuit issued a decision that was subsequently withdrawn and a reconstituted panel conferred on the appeal. On June 7, 2019, the Ninth Circuit reversed the decision of the U.S. Tax Court and upheld the cost-sharing regulations. On February 10, 2020, Altera Corp. filed a Petition for a Writ of Certiorari with the Supreme Court of the United States, which was denied by the Supreme Court on June 22, 2020. Although the issue is now resolved within the Ninth Circuit, the Ninth Circuit's opinion is not binding in other circuits. The potential impact of this issue on the Company, which is not located within the jurisdiction of the Ninth Circuit, is unclear at this time. We will continue to monitor developments related to this issue and the potential impact of those developments on the Company's current and prior fiscal years. The following table summarizes the changes in the unrecognized tax benefits (in thousands): March 25, March 26, Beginning balance $ 32,879 $ 32,879 Additions based on tax positions related to the current year — — Reductions based on tax positions related to the prior years — — Ending balance $ 32,879 $ 32,879 At March 25, 2023, the Company had gross unrecognized tax benefits of $32.9 million, all of which would impact the effective tax rate if recognized. The Company’s unrecognized tax benefits are classified as “ Non-current income taxes ” in the consolidated balance sheet. The Company recognizes interest and penalties related to unrecognized tax benefits in the provision for income taxes. During fiscal years 2023 and 2022 we recognized interest expense, net of tax, of approximately $1.7 million and $0.9 million, respectively. The total amount of interest accrued as of March 25, 2023 was $6.8 million. The Company and its subsidiaries are subject to U.S. federal income tax as well as income tax in multiple state and foreign jurisdictions. Fiscal years 2017 through 2023 remain open to examination by the major taxing jurisdictions to which the Company is subject, although carry forward attributes that were generated in tax years prior to fiscal year 2017 may be adjusted upon examination by the tax authorities if they have been, or will be, used in a future period. The Company's fiscal year 2017, 2018, and 2019 federal income tax returns are under examination by the U.S. Internal Revenue Service ("IRS"). The IRS has proposed adjustments that would increase U.S. taxable income related to transfer pricing matters with respect to our U.S. and U.K. affiliated companies and on May 17, 2022, the IRS issued a Revenue Agent’s Report asserting additional tax of approximately $170.5 million plus interest and imposing penalties of approximately $63.7 million. We do not agree with the IRS's positions and we intend to vigorously dispute the proposed adjustments. We intend to pursue resolution through the administrative process with the IRS Independent Office of Appeals and, if necessary, through judicial remedies. We expect it could take a number of years to reach resolution on these matters. Although the final resolution |
Segment Information
Segment Information | 12 Months Ended |
Mar. 25, 2023 | |
Segment Reporting [Abstract] | |
Segment Information | Segment Information We determine our operating segments in accordance with Financial Accounting Standards Board (“FASB”) guidelines. Our Chief Executive Officer (“CEO”) has been identified as the chief operating decision maker under these guidelines. The Company operates and tracks its results in one reportable segment, but reports revenue performance in two product lines: Audio and HPMS. Our CEO receives and uses enterprise-wide financial information to assess financial performance and allocate resources, rather than detailed information at a product line level. Additionally, our product lines have similar characteristics and customers. They share operations support functions such as sales, public relations, supply chain management, various research and development and engineering support, in addition to the general and administrative functions of human resources, legal, finance and information technology. Therefore, there is no complete, discrete financial information maintained for these product lines. Revenue by product line is disclosed in Note 10 - Revenues. Geographic details of revenue and property, plant and equipment are included below. Geographic Area The following illustrates sales by ship to location of the customer (in thousands): Fiscal Years Ended March 25, March 26, March 27, China $ 1,230,602 $ 1,197,812 $ 1,024,178 Hong Kong 223,405 325,433 170,605 Vietnam 93,760 72,162 10,115 South Korea 93,177 51,606 42,403 India 69,343 18,257 14,481 United States 52,688 29,513 21,708 Rest of World 134,642 86,677 85,740 Total consolidated sales $ 1,897,617 $ 1,781,460 $ 1,369,230 The following illustrates property, plant and equipment, net, by geographic locations, based on physical location (in thousands): Fiscal Years Ended March 25, March 26, United States $ 132,633 $ 118,847 United Kingdom 20,675 28,612 Rest of World 9,664 9,618 Total consolidated property, plant and equipment, net $ 162,972 $ 157,077 |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Policies) | 12 Months Ended |
Mar. 25, 2023 | |
Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation We prepare financial statements on a 52- or 53-week year that ends on the last Saturday in March. Fiscal years 2023, 2022, and 2021 were 52-week years. The next 53-week year will be fiscal year 2024. |
Principles of Consolidation | Principles of Consolidation The accompanying consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (U.S. GAAP) and include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated. |
Reclassifications | Reclassifications Certain reclassifications have been made to prior year balances in order to conform to the current year’s presentation of financial information. |
Use of Estimates | Use of Estimates The preparation of financial statements in accordance with U.S. GAAP requires the use of management estimates. These estimates are subjective in nature and involve judgments that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at fiscal year-end and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from these estimates. |
Cash and Cash Equivalents | Cash and Cash Equivalents Cash and cash equivalents consist primarily of money market funds, commercial paper, and U.S. Government Treasury and Agency instruments with original maturities of three months or less at the date of purchase. |
Business Combinations | Business Combinations We account for business combinations using the acquisition method of accounting and allocate the fair value of acquisition consideration to the assets acquired and liabilities assumed based on their fair values at the acquisition date. The excess of the fair value of purchase consideration over the fair value of the assets acquired and liabilities assumed is recorded as goodwill. The results of operations of the business acquired is included in our consolidated statements of income beginning on the date of the acquisition. |
Leases | Leases We account for leases under ASC 842, Leases. Our leases generally contain fixed rental payments, with additional variable payments linked to actual common area maintenance costs incurred by the landlord. These variable payments are not included within the lease liability and right-of-use ("ROU") asset, but are recognized as an expense when incurred. As our leases typically do not provide an implicit rate, the Company determines the Incremental Borrowing Rate ("IBR") for each lease based on the information available at the commencement date, taking into consideration necessary adjustments for collateral, currency, and lease term. |
Inventories | Inventories We use the lower of cost or net realizable value to value our inventories, with cost being determined on a first-in, first-out basis. One of the factors we consistently evaluate in the application of this method is the extent to which products are accepted into the marketplace. By policy, we evaluate market acceptance based on known business factors and conditions by comparing forecasted customer unit demand for our products over a specific future period, or demand horizon, to quantities on hand at the end of each accounting period. On a quarterly and annual basis, we analyze inventories on a part-by-part basis. Product life cycles and the competitive nature of the industry are factors considered in the evaluation of customer unit demand at the end of each quarterly accounting period. Inventory on-hand in excess of forecasted demand is considered to have reduced market value and, therefore, the cost basis is adjusted to the lower of cost or net realizable value. Typically, market values for excess or obsolete inventories are considered to be zero. Inventory charges recorded for excess and obsolete inventory, including scrapped inventory, were $9.9 million and $6.5 million, in fiscal year 2023 and 2022, respectively. Inventory charges in fiscal year 2023 and 2022 related to a combination of quality issues and inventory exceeding demand. |
Property, Plant and Equipment, net | Property, Plant and Equipment, netProperty, plant and equipment is recorded at cost, net of depreciation and amortization. Depreciation and amortization is calculated on a straight-line basis over estimated economic lives, ranging from 3 to 39 years. Leasehold improvements are depreciated over the shorter of the term of the lease or the estimated useful life. Furniture, fixtures, machinery, and equipment are all depreciated over a useful life of 3 to 10 years, while buildings are depreciated over a period of up to 39 years. In general, our capitalized software is amortized over a useful life of 3 years, with capitalized enterprise resource planning software being amortized over a useful life of 10 years. Gains or losses related to retirements or dispositions of fixed assets are recognized in the period incurred. Additionally, if impairment indicators exist, the Company will assess the carrying value in relation to the calculated fair value of the associated asset. |
Goodwill | Goodwill Goodwill is recorded at the time of an acquisition and is calculated as the difference between the aggregate consideration paid for an acquisition and the fair value of the net tangible and intangible assets acquired. The Company tests goodwill for impairment on an annual basis or more frequently if the Company believes indicators of impairment exist. Impairment evaluations involve management’s assessment of qualitative factors to determine whether it is more likely than not that goodwill is impaired. If management concludes from its assessment of qualitative factors that it is more likely than not that impairment exists, then a quantitative impairment test will be performed involving management estimates of future cash flows. Significant management judgment is required in the forecasts of future operating results that are used in these evaluations. Following the quantitative test, an impairment charge would be recorded for the amount the carrying value exceeds the calculated fair value. |
Long-Lived Assets | Long-Lived Assets Intangible assets include purchased technology licenses and patents that are reported at cost and are amortized on a straight-line basis over their useful lives, generally ranging from 1 to 5 years. Acquired intangibles include existing technology, core technology or patents, license agreements, in-process research & development, trademarks, tradenames, customer relationships, and non-compete agreements. These assets are amortized on a straight-line basis over lives ranging from 1 to 15 years. We regularly review whether facts or circumstances exist that indicate the carrying values of property, plant and equipment or other long-lived assets, including intangible assets, are impaired. We assess the recoverability of assets by comparing the projected undiscounted net cash flows associated with those assets to their respective carrying amounts. We measure any impairment loss by comparing the fair value of the asset to its carrying amount. We estimate fair value based on discounted future cash flows, quoted market prices, or independent appraisals. During the fourth quarter of fiscal year 2023, the Company recorded $85.8 million of acquired intangible asset impairment charges. See Note 7 — Intangibles, net and Goodwill for further detail. There were |
Foreign Currency Translation | Foreign Currency TranslationSome of the Company's subsidiaries utilize the local currency as the functional currency. The Company’s main entities, including the entities that generate the majority of sales and employ the majority of employees, are U.S. dollar functional. |
Concentration of Credit Risk | Concentration of Credit Risk Financial instruments that potentially subject us to material concentrations of credit risk consist primarily of cash equivalents, marketable securities, long-term marketable securities, and trade accounts receivable. We are exposed to credit risk to the extent of the amounts recorded on the balance sheet. By policy, our cash equivalents, marketable securities, and long-term marketable securities are subject to certain nationally recognized credit standards, issuer concentrations, sovereign risk, and marketability or liquidity considerations. In evaluating our trade receivables, we perform credit evaluations of our major customers’ financial condition and monitor closely all of our receivables to limit our financial exposure by limiting the length of time and amount of credit extended. In certain situations, we may require payment in advance or utilize letters of credit to reduce credit risk. By policy, we establish a reserve for trade accounts receivable based on the type of business in which a customer is engaged, the length of time a trade account receivable is outstanding, and other knowledge that we may possess relating to the probability that a trade receivable is at risk for non-payment. We had three contract manufacturers aggregated at their parent level, Foxconn, Pegatron and Luxshare Precision, who represented 35 percent, 16 percent, 11 percent, respectively, of our consolidated gross trade accounts receivable as of the end of fiscal year 2023. We had two contract manufacturers aggregated at their parent level, Foxconn and Pegatron, who represented 49 percent and 17 percent, respectively, of our consolidated gross trade accounts receivable as of the end of fiscal year 2022. No other distributor or contract manufacturer had receivable balances that represented more than 10 percent of consolidated gross trade accounts receivable as of the end of fiscal year 2023 or 2022. Since the components we produce are largely proprietary and generally not available from second sources, we consider our end customer to be the entity specifying the use of our component in their design. These end customers may then purchase our products directly from us, from a distributor, or through a third-party manufacturer contracted to produce their end product. For fiscal year 2023, our ten largest end customers represented approximately 92 percent and for each of fiscal years 2022 and 2021, our ten largest end customers represented 93 percent of our sales. For fiscal years 2023, 2022, and 2021, we had one end customer, Apple Inc., who purchased through multiple contract manufacturers and represented approximately 83 percent, 79 percent, and 83 percent, of the Company’s total sales, respectively. No other customer or distributor represented more than 10 percent of net sales in fiscal years 2023, 2022, or 2021. |
Revenue Recognition, Shipping Costs | Revenue Recognition We recognize revenue upon the transfer of promised goods or services to customers, in an amount that reflects the consideration the Company expects to be entitled in exchange for those goods or services. Performance Obligations The Company’s single performance obligation is the delivery of promised goods to the customer. The promised goods are explicitly stated in the customer contract and are comprised of a single type of good. This performance obligation is satisfied upon transfer of control of the promised goods to the customer, as defined per the shipping terms within the customer’s contract. The vast majority of the Company’s contracts with customers have an original expected term of one year or less. A s allowed by ASC 606, the Company has not disclosed the value of any unsatisfied performance obligations related to these contracts. Contract balances Payments are typically due within 30 to 60 days of invoicing and terms do not include a significant financing component or noncash consideration. There have been no material impairment losses on accounts receivable. There are no material contract assets or contract liabilities recorded on the consolidated balance sheets. Transaction price The transaction price is the amount of consideration to which the Company expects to be entitled in exchange for transferring the promised goods to the customer. Fixed pricing is the consideration that is agreed upon in the customer contract. Variable pricing includes rights of return, price protection and stock rotation. Rights of return costs are estimated using the "most likely amount" method by reviewing historical returns to determine the most likely customer return rate and applying materiality thresholds. Price protection includes price adjustments available to certain distributors based upon established book price and a stated adjustment period. Stock rotation is also available to certain distributors based on a stated maximum of prior billings. The Company estimates all variable consideration at the most likely amount which it expects to be entitled. The estimate is based on current and historical information available to the Company, including recent sales activity and pricing. Variable consideration is only included in the transaction price to the extent that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved. The Company defers all variable consideration that does not meet the revenue recognition criteria. Shipping Costs Our shipping and handling costs are included in cost of sales for all periods presented in the consolidated statements of income. Disaggregation of revenue We disaggregate revenue from contracts with customers by product line and ship to location of the customer. Sales are designated in the product line categories of Audio and High-Performance Mixed-Signal ("HPMS"). Total net sales based on the product line disaggregation criteria described above are shown in the table below (in thousands). Fiscal Years Ended March 25, 2023 March 26, 2022 March 27, 2021 Audio Products $ 1,172,007 $ 1,187,126 $ 1,104,060 HPMS Products 725,610 594,334 265,170 Total $ 1,897,617 $ 1,781,460 $ 1,369,230 |
Advertising Costs | Advertising CostsAdvertising costs are expensed as incurred. |
Stock-Based Compensation | Stock-Based Compensation Stock-based compensation is measured at the grant date based on the grant-date fair value of the awards and is recognized as an expense, on a ratable basis, over the vesting period, which is generally between 1 and 4 years. Determining the amount of stock-based compensation to be recorded requires the Company to develop estimates used in calculating the grant-date fair value of stock options and performance awards (also called market stock units). The Company calculates the grant-date fair value for stock options and market stock units using the Black-Scholes valuation model and the Monte Carlo simulation, respectively. The use of valuation models requires the Company to make estimates of assumptions such as expected volatility, expected term, risk-free interest rate, expected dividend yield, and forfeiture rates. The grant-date fair value of restricted stock units is the market value at grant date multiplied by the number of units. |
Income Taxes | Income Taxes We are required to calculate income taxes in each of the jurisdictions in which we operate. This process involves calculating the actual current tax liability as well as assessing temporary differences in the recognition of income or loss for tax and accounting purposes. These differences result in deferred tax assets and liabilities, which are included in our consolidated balance sheet. We record a valuation allowance when it is more likely than not that some portion or all of the deferred tax assets will not be realized. The Company evaluates the ability to realize its deferred tax assets based on all the facts and circumstances, including projections of future taxable income and expiration dates of carryover tax attributes. The calculation of our tax liabilities involves assessing uncertainties with respect to the application of complex tax rules and the potential for future adjustment of our uncertain tax positions by the U.S. Internal Revenue Service or other taxing jurisdiction. We recognize liabilities for uncertain tax positions based on the required two-step process. The first step requires us to determine if the weight of available evidence indicates that the tax position has met the threshold for recognition; therefore, we must evaluate whether it is more likely than not that the position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step requires us to measure the tax benefit of the tax position taken, or expected to be taken, in an income tax return as the largest amount that is more than 50 percent likely of being realized upon ultimate settlement. We reevaluate the uncertain tax positions each quarter based on factors including, but not limited to, changes in facts or circumstances, changes in tax law, expirations of statutes of limitation, effectively settled issues under audit, and new audit activity. A change in the recognition step or measurement step would result in the recognition of a tax benefit or an additional charge to the tax provision in the period. Although we believe the measurement of our liabilities for uncertain tax positions is reasonable, we cannot assure that the final outcome of these matters will not be different than what is reflected in the historical income tax provisions and accruals. If additional taxes are assessed as a result of an audit or litigation, it could have a material effect on our income tax provision and net income in the period or periods for which that determination is made. We operate within multiple taxing jurisdictions and are subject to audit in these jurisdictions. These audits can involve complex issues which may require an extended period of time to resolve and could result in additional assessments of income tax. We believe adequate provisions for income taxes have been made for all periods. See Note 19 - Income Taxes for further detail. Government Assistance The Company benefits from the Research and Development Expenditure Credit (“RDEC”) program in the United Kingdom. The RDEC is recorded as an offset to research and development expenses in the consolidated statements of income Other current Assets " and " Other assets |
Net Income Per Share | Net Income Per Share Basic net income per share is based on the weighted effect of common shares issued and outstanding and is calculated by dividing net income by the basic weighted average shares outstanding during the period. Diluted net income per share is calculated by dividing net income by the weighted average number of common shares used in the basic net income per share calculation, plus the equivalent number of common shares that would be issued assuming exercise or conversion of all potentially dilutive common shares outstanding. These potentially dilutive items consist primarily of outstanding stock options and restricted stock grants. |
Accumulated Other Comprehensive Loss | Accumulated Other Comprehensive Loss Our accumulated other comprehensive loss is comprised of foreign currency translation adjustments and unrealized gains and losses on investments classified as available-for-sale. See Note 18 — Accumulated Other Comprehensive Income (Loss) for additional discussion. |
Recently Adopted Accounting Pronouncements | Recently Adopted Accounting Pronouncements In November 2021, the FASB issued ASU No. 2021-10, Government Assistance (Topic 832) – Disclosures by Business Entities about Government Assistance, which requires annual disclosures about transactions with a government that are accounted for by applying a grant or contribution type accounting model. The disclosures requires information about the nature and related policy used for the transactions, the line items on the balance sheet and income statement that are affected and the amounts applicable to each financial statement line item, and significant terms and conditions of the transactions. This ASU is effective for financial statements issued for annual periods beginning after December 15, 2021. The Company adopted this ASU in the fourth quarter of fiscal year 2023 on a prospective basis. See related policy discussion above. In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 805) – Accounting for Contract Assets and Contract Liabilities from Contracts with Customers , which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured at the acquisition date in accordance with Revenue from Contracts with Customers (Topic 606) as if the acquirer had originated the contracts . Prior to the issuance of this ASU, contract assets and liabilities were recognized at fair value on the acquisition date. This ASU is effective for fiscal years beginning after December 15, 2022, including interim periods within that fiscal year, with early adoption permitted, and should be applied on a prospective basis. The Company early adopted this ASU in the fourth quarter of fiscal year 2023 with no material impact to the financial statements. |
Marketable Securities | The Company’s investments have been classified as available-for-sale securities in accordance with U.S. GAAP. Marketable securities are categorized on the consolidated balance sheet as “ Marketable securities” within the short-term or long-term classification, as appropriate. |
Summary of Significant Accoun_3
Summary of Significant Accounting Policies (Tables) | 12 Months Ended |
Mar. 25, 2023 | |
Accounting Policies [Abstract] | |
Schedule of Inventories | Inventories were comprised of the following (in thousands): March 25, 2023 March 26, 2022 Work in process $ 116,088 $ 95,188 Finished goods 117,362 43,248 $ 233,450 $ 138,436 |
Components of Property, Plant and Equipment | Property, plant and equipment was comprised of the following (in thousands): March 25, 2023 March 26, 2022 Land $ 23,853 $ 23,853 Buildings 64,056 63,730 Furniture and fixtures 23,909 24,122 Leasehold improvements 55,733 53,611 Machinery and equipment 188,403 175,966 Capitalized software 26,889 26,491 Construction in progress and other 14,350 5,566 Total property, plant and equipment 397,193 373,339 Less: Accumulated depreciation and amortization (234,221) (216,262) Property, plant and equipment, net $ 162,972 $ 157,077 |
Schedule of Earnings Per Share, Basic and Diluted | The following table details the calculation of basic and diluted earnings per share for fiscal years 2023, 2022, and 2021, (in thousands, except per share amounts): Fiscal Years Ended March 25, 2023 March 26, 2022 March 27, 2021 Numerator: Net income $ 176,703 $ 326,355 $ 217,344 Denominator: Weighted average shares outstanding 55,614 57,278 58,106 Effect of dilutive securities 1,612 1,865 1,954 Weighted average diluted shares 57,226 59,143 60,060 Basic earnings per share $ 3.18 $ 5.70 $ 3.74 Diluted earnings per share $ 3.09 $ 5.52 $ 3.62 |
Marketable Securities (Tables)
Marketable Securities (Tables) | 12 Months Ended |
Mar. 25, 2023 | |
Marketable Securities [Abstract] | |
Schedule of Available-for-sale Securities | The following table is a summary of available-for-sale securities (in thousands): As of March 25, 2023 Amortized Gross Unrealized Gross Unrealized Estimated Fair Value Corporate debt securities $ 66,753 $ 91 $ (1,825) $ 65,019 Non-U.S. government securities 510 — (3) 507 U.S. Treasury securities 5,728 17 (151) 5,594 Agency discount notes 385 — (18) 367 Total securities $ 73,376 $ 108 $ (1,997) $ 71,487 As of March 26, 2022 Amortized Gross Unrealized Gross Unrealized Estimated Fair Value Corporate debt securities $ 70,296 $ 2 $ (2,133) $ 68,165 Non-U.S. government securities 509 — (9) 500 U.S. Treasury securities 5,483 — (169) 5,314 Agency discount notes 385 — (14) 371 Total securities $ 76,673 $ 2 $ (2,325) $ 74,350 |
Schedule of Cost and Estimated Fair Value of Available-for-sale Securities by Contractual Maturity | The cost and estimated fair value of available-for-sale investments by contractual maturity were as follows: March 25, 2023 March 26, 2022 Amortized Estimated Amortized Estimated Within 1 year $ 35,824 $ 34,978 $ 10,697 $ 10,601 After 1 year 37,552 36,509 65,976 63,749 Total $ 73,376 $ 71,487 $ 76,673 $ 74,350 |
Fair Value of Financial Instr_2
Fair Value of Financial Instruments (Tables) | 12 Months Ended |
Mar. 25, 2023 | |
Fair Value Disclosures [Abstract] | |
Schedule of Fair Value of Financial Assets and Liabilities | The following summarizes the fair value of our financial instruments at March 25, 2023 (in thousands): Quoted Prices Significant Significant Total Assets: Cash equivalents Money market funds $ 406,265 $ — $ — $ 406,265 Available-for-sale securities Corporate debt securities $ — $ 65,019 $ — $ 65,019 Non-U.S. government securities — 507 — 507 U.S. Treasury securities 5,594 — — 5,594 Agency discount notes — 367 — 367 $ 5,594 $ 65,893 $ — $ 71,487 The following summarizes the fair value of our financial instruments at March 26, 2022 (in thousands): Quoted Prices Significant Significant Total Assets: Cash equivalents Money market funds $ 217,151 $ — $ — $ 217,151 Commercial paper — 249 — 249 $ 217,151 $ 249 $ — $ 217,400 Available-for-sale securities Corporate debt securities $ — $ 68,165 $ — $ 68,165 Non-U.S. government securities — 500 — 500 U.S. Treasury securities 5,314 — — 5,314 Agency discount notes — 371 — 371 $ 5,314 $ 69,036 $ — $ 74,350 |
Derivative Financial Instrume_2
Derivative Financial Instruments (Tables) | 12 Months Ended |
Mar. 25, 2023 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Schedule of Before-Tax Effect of Derivative Instruments Not Designated as Hedging Instruments | The before-tax effect of derivative instruments not designated as hedging instruments was as follows (in thousands): Fiscal Years Ended March 25, 2023 March 26, 2022 March 27, 2021 Location Gain (loss) recognized in income Foreign currency forward contracts $ (564) $ (283) $ 3,212 Other income (expense) |
Accounts Receivable, net (Table
Accounts Receivable, net (Tables) | 12 Months Ended |
Mar. 25, 2023 | |
Accounts Receivable, after Allowance for Credit Loss [Abstract] | |
Components of Accounts Receivable, Net | The following are the components of accounts receivable, net (in thousands): March 25, 2023 March 26, 2022 Gross accounts receivable $ 150,473 $ 240,264 Allowance for doubtful accounts — — Accounts receivable, net $ 150,473 $ 240,264 |
Intangibles, net and Goodwill (
Intangibles, net and Goodwill (Tables) | 12 Months Ended |
Mar. 25, 2023 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Schedule of Gross Carrying Amount and Amortization of Intangible Assets | The following information details the gross carrying amount, accumulated amortization, and net carrying value of our intangible assets subject to amortization (in thousands): March 25, 2023 March 26, 2022 Intangible Category / Gross Accumulated Net Carrying Value Gross Accumulated Net Carrying Value Existing technology (5.3) 146,146 (110,792) 35,354 255,995 (124,127) 131,868 In-process research & development (a) 70,936 (70,936) — 70,936 (67,486) 3,450 Trademarks and tradename (0.5) 3,037 (2,973) 64 3,037 (2,845) 192 Customer relationships (1.4) 15,381 (13,422) 1,959 34,091 (14,379) 19,712 Technology licenses (1.7) 23,490 (21,991) 1,499 22,376 (19,453) 2,923 Total $ 258,990 $ (220,114) $ 38,876 $ 386,435 $ (228,290) $ 158,145 (a) Intangible assets are fully amortized as of March 25, 2023. |
Schedule of Estimated Aggregate Amortization Expense for Intangibles | The following table details the estimated aggregate amortization expense for all intangibles owned as of March 25, 2023, for each of the five succeeding fiscal years and in the aggregate thereafter (in thousands): Fiscal Year 2024 $ 9,221 2025 $ 7,600 2026 $ 6,681 2027 $ 6,589 2028 $ 6,589 Thereafter $ 2,196 |
Revolving Credit Facility (Tabl
Revolving Credit Facility (Tables) | 12 Months Ended |
Mar. 25, 2023 | |
Debt Disclosure [Abstract] | |
Schedule of Future Interest Payment Obligations | As of March 25, 2023, future interest payment obligations based on forecasted commitment fees under the Revolving Credit Facility were as follows (in thousands): Fiscal Year 2024 $ 528 2025 534 2026 532 2027 277 2028 — Thereafter — Total $ 1,871 |
Revenues (Tables)
Revenues (Tables) | 12 Months Ended |
Mar. 25, 2023 | |
Revenue from Contract with Customer [Abstract] | |
Disaggregation of Revenue | Total net sales based on the product line disaggregation criteria described above are shown in the table below (in thousands). Fiscal Years Ended March 25, 2023 March 26, 2022 March 27, 2021 Audio Products $ 1,172,007 $ 1,187,126 $ 1,104,060 HPMS Products 725,610 594,334 265,170 Total $ 1,897,617 $ 1,781,460 $ 1,369,230 Total net sales based on the geographic disaggregation criteria described are as follows (in thousands): Fiscal Years Ended March 25, March 26, March 27, 2023 2022 2021 China $ 1,230,602 $ 1,197,812 $ 1,024,178 United States 52,688 29,513 21,708 Rest of World 614,327 554,135 323,344 Total $ 1,897,617 $ 1,781,460 $ 1,369,230 |
Leases (Tables)
Leases (Tables) | 12 Months Ended |
Mar. 25, 2023 | |
Leases [Abstract] | |
Schedule of Lease Expense and Other Information | The components of net operating lease expense were as follows (in thousands): Fiscal Years Ended March 25, 2023 March 26, 2022 Operating lease - in excess of 12 months $ 18,071 $ 14,901 Variable lease 6,226 4,954 Short-term lease 86 22 Operating lease income (464) (1,518) Total net operating lease expense $ 23,919 $ 18,359 Supplemental operating lease information: Fiscal Years Ended March 25, 2023 March 26, 2022 Balance Sheet Information (in thousands) Operating lease right-of-use assets $ 128,145 $ 171,003 Operating lease liabilities $ 141,073 $ 177,842 Cash Flow Information (in thousands) Operating cash flows from operating leases $ 14,531 $ 14,634 Non-Cash Information Right-of-use assets obtained in exchange for new operating lease liabilities 4,381 46,123 Lease remeasurements (28,965) — Lease impairments (5,579) — Operating Lease Information Weighted-average remaining lease term - operating leases (in years) 13 16 Weighted-average discount rate - operating leases 4 % 4 % |
Schedule of Operating Lease Expense | The components of net operating lease expense were as follows (in thousands): Fiscal Years Ended March 25, 2023 March 26, 2022 Operating lease - in excess of 12 months $ 18,071 $ 14,901 Variable lease 6,226 4,954 Short-term lease 86 22 Operating lease income (464) (1,518) Total net operating lease expense $ 23,919 $ 18,359 |
Schedule of Future Lease Commitments, Operating Lease Expense | Future lease commitments under non-cancellable leases, including extension options reasonably anticipated to be exercised as of March 25, 2023, are as follows (in thousands): Fiscal Year Operating Lease Expense 2024 $ 18,631 2025 19,598 2026 18,043 2027 16,489 2028 16,882 Thereafter 106,651 Total $ 196,294 Less imputed interest and other (55,221) Total $ 141,073 |
Schedule of Lease Liabilities | Operating lease liabilities consisted of the following (in thousands): March 25, 2023 March 26, 2022 Current lease liabilities $ 18,442 $ 14,680 Non-current lease liabilities 122,631 163,162 Total operating lease liabilities $ 141,073 $ 177,842 |
Equity Compensation (Tables)
Equity Compensation (Tables) | 12 Months Ended |
Mar. 25, 2023 | |
Share-Based Payment Arrangement, Noncash Expense [Abstract] | |
Summary of Activity in Total Stock Available for Grant | The following table summarizes the activity in total shares available for grant (in thousands): Shares Available for Grant Balance, March 28, 2020 2,095 Shares added 3,223 Granted (1,491) Forfeited 198 Balance, March 27, 2021 4,025 Shares added — Granted (1,679) Forfeited 271 Balance, March 26, 2022 2,617 Shares added 2,090 Granted (2,536) Forfeited 303 Balance, March 25, 2023 2,474 |
Summary of Effect of Stock-Based Compensation | The following table summarizes the effects of stock-based compensation on cost of goods sold, research and development, sales, general and administrative, pre-tax income, and net income after taxes for shares granted under the Plan (in thousands, except per share amounts): Fiscal Year 2023 2022 2021 Cost of sales $ 1,270 $ 1,024 $ 900 Research and development 57,312 44,154 37,483 Sales, general and administrative 23,059 21,214 18,379 Effect on pre-tax income 81,641 66,392 56,762 Income Tax Benefit (15,184) (11,521) (9,558) Total stock-based compensation expense (net of taxes) 66,457 54,871 47,204 Stock-based compensation effects on basic earnings per share $ 1.19 $ 0.96 $ 0.81 Stock-based compensation effects on diluted earnings per share 1.16 0.93 0.79 |
Schedule of Fair Value of Stock Option Grants | We estimate the fair value of each stock option on the date of grant using the Black-Scholes option-pricing model using a dividend yield of zero and the following additional assumptions: March 25, 2023 March 26, 2022 March 27, 2021 Expected stock price volatility 35.18% - 46.50% 36.85% - 41.66% 43.85% - 43.99% Risk-free interest rate 2.47% - 3.96% 0.82% - 1.62% 0.35% - 0.72% Expected term (in years) 4.04 - 4.33 4.22 - 4.39 4.32 - 4.43 |
Schedule of Stock Option Activity | Additional information with respect to stock option activity is as follows (in thousands, except per share amounts): Outstanding Options Number Weighted Balance, March 28, 2020 1,216 $ 44.01 Options granted 96 77.23 Options exercised (236) 30.26 Options forfeited (17) 56.27 Options expired — — Balance, March 27, 2021 1,059 $ 49.87 Options granted 88 87.52 Options exercised (327) 40.31 Options forfeited — — Options expired — — Balance, March 26, 2022 820 $ 57.75 Options granted 143 96.33 Options exercised (225) 45.10 Options forfeited (18) 71.14 Options expired — — Balance, March 25, 2023 720 $ 69.03 |
Summary of Outstanding Options Vesting, Expected to Vest, or Exercisable | Additional information with regards to outstanding options that are vesting, expected to vest, or exercisable as of March 25, 2023 is as follows (in thousands, except years and per share amounts): Number of Weighted Weighted Average Aggregate Vested and expected to vest 709 $ 68.63 6.67 $ 26,208 Exercisable 452 $ 57.01 5.37 $ 21,955 |
Summary of Outstanding and Exercisable Options | The following table summarizes information regarding outstanding and exercisable options as of March 25, 2023 (in thousands, except per share amounts): Options Outstanding Options Exercisable Weighted Average Weighted Number Weighted Range of Exercise Prices Number (years) Price Exercisable Exercise Price $20.37 - $54.65 200 4.30 $ 45.06 200 $ 45.06 $55.72 - $68.56 215 5.70 62.55 193 61.83 $78 - $82.14 100 8.20 78.53 39 78.27 $82.81 - $82.81 21 9.11 82.81 — — $88 - $88 81 8.94 88.00 20 88.00 $102.37 - $102.37 103 9.87 102.37 — — 720 6.71 $ 69.03 452 $ 57.01 |
Summary of Restricted Stock and Restricted Stock Units Activity | A summary of the activity for RSUs in fiscal year 2023, 2022, and 2021 is presented below (in thousands, except per share amounts): Shares Weighted March 28, 2020 2,680 $ 53.74 Granted 945 71.44 Vested (881) 52.97 Forfeited (131) 55.36 March 27, 2021 2,613 $ 60.31 Granted 1,079 81.61 Vested (935) 43.96 Forfeited (181) 70.60 March 26, 2022 2,576 $ 74.45 Granted 1,574 75.97 Vested (877) 70.02 Forfeited (183) 75.58 March 25, 2023 3,090 $ 76.42 |
Summary of Restricted Stock Units Vesting or Expected to Vest | Additional information with regards to outstanding RSUs that are expected to vest as of March 25, 2023, is as follows (in thousands, except year and per share amounts): Shares Weighted Weighted Average Expected to vest 2,896 $ 76.42 1.60 |
Summary of Monte Carlo Simulation Assumptions for Market Stock Units | The fair values estimated from the Monte Carlo simulation were calculated using a dividend yield of zero and the following additional assumptions: Fiscal Years Ended March 25, March 26, March 27, Expected stock price volatility 35.18% - 46.50% 41.66 % 43.85 % Risk-free interest rate 2.67% - 3.92% 1.46 % 0.29 % Expected term (in years) 3.00 3.00 3.00 |
Schedule of Market Stock Units Activity | A summary of the activity for MSUs in fiscal year 2023, 2022, and 2021 is presented below (in thousands, except per share amounts): Shares Weighted March 28, 2020 153 $ 68.71 Granted 28 83.96 Vested — — Forfeited (48) 64.92 March 27, 2021 133 $ 73.29 Granted 28 109.18 Vested (30) 50.11 Forfeited (46) 38.70 March 26, 2022 85 $ 95.75 Granted 38 135.87 Vested (10) 87.43 Forfeited (24) 94.80 March 25, 2023 89 $ 113.83 |
Summary of Outstanding MSUs Expected to Vest | Additional information with regard to outstanding MSUs that are expected to vest as of March 25, 2023 is as follows (in thousands, except year and per share amounts): Shares Weighted Weighted Average Expected to vest 82 $ 113.13 2.00 |
Commitment and Contingencies (T
Commitment and Contingencies (Tables) | 12 Months Ended |
Mar. 25, 2023 | |
Commitments and Contingencies Disclosure [Abstract] | |
Long-term Purchase Commitment | Total future unconditional purchase commitments as of March 25, 2023 were as follows (in thousands): Fiscal Year 2024 $ 563,177 2025 379,973 2026 255,222 2027 164,425 2028 2,658 Thereafter — Total $ 1,365,455 |
Accumulated Other Comprehensi_2
Accumulated Other Comprehensive Income (Loss) (Tables) | 12 Months Ended |
Mar. 25, 2023 | |
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] | |
Summary of Changes in the Components of Accumulated Other Comprehensive Income (Loss) | The following table summarizes the changes in the components of accumulated other comprehensive income (loss), net of tax (in thousands): Foreign Unrealized Gains Cumulative Effect of Adoption of ASU 2018-02 Total Balance, March 27, 2021 $ 294 $ 2,838 $ (257) $ 2,875 Current period foreign exchange translation (507) — — (507) Current period marketable securities activity — (5,587) — (5,587) Tax effect — 1,174 — 1,174 Balance, March 26, 2022 $ (213) $ (1,575) $ (257) $ (2,045) Current period foreign exchange translation (834) — — (834) Current period marketable securities activity — 430 — 430 Tax effect — (90) — (90) Balance, March 25, 2023 $ (1,047) $ (1,235) $ (257) $ (2,539) |
Income Taxes (Tables)
Income Taxes (Tables) | 12 Months Ended |
Mar. 25, 2023 | |
Income Tax Disclosure [Abstract] | |
Summary of Income Before Income Taxes | Income (loss) before income taxes consisted of (in thousands): Fiscal Years Ended March 25, March 26, March 27, U.S. $ (141,670) $ (17,674) $ 19,189 Non-U.S. 396,409 386,337 226,057 $ 254,739 $ 368,663 $ 245,246 |
Summary of Provision (Benefit) for Income Taxes | The provision (benefit) for income taxes consists of (in thousands): Fiscal Years Ended March 25, March 26, March 27, Current: U.S. $ 60,603 $ 4,483 $ 981 Non-U.S. 52,023 52,920 32,428 Total current tax provision $ 112,626 $ 57,403 $ 33,409 Deferred: U.S. (28,529) (6,256) (192) Non-U.S. (6,061) (8,839) (5,315) Total deferred tax provision (34,590) (15,095) (5,507) Total tax provision $ 78,036 $ 42,308 $ 27,902 |
Summary of Provision (Benefit) for Income Taxes, Statutory Federal Rate Pretax Income Reconciliation | The effective income tax rates differ from the rates computed by applying the statutory federal rate to pretax income as follows (in percentages): Fiscal Years Ended March 25, March 26, March 27, U.S. federal statutory rate 21.0 21.0 21.0 Foreign income taxed at different rates (14.4) (9.6) (8.4) Stock-based compensation (0.3) (0.9) (0.8) Foreign-derived intangible income deduction — (0.1) (0.3) GILTI and Subpart F income 30.6 10.0 7.8 Foreign tax credits (7.7) (9.4) (7.4) Change in valuation allowance 0.2 (0.2) — Release of prior year unrecognized tax benefits — — (1.4) Interest related to unrecognized tax benefits 0.7 0.2 0.3 Other 0.5 0.5 0.6 Effective tax rate 30.6 11.5 11.4 |
Significant Components of Deferred Tax Assets and Liabilities | Significant components of our deferred tax assets and liabilities as of March 25, 2023 and March 26, 2022 are (in thousands): March 25, March 26, Deferred tax assets: Accrued expenses and allowances $ 7,913 $ 6,517 Net operating loss carryforwards 1,132 1,713 Research and development tax credit carryforwards 13,283 15,230 Stock-based compensation 24,842 18,952 Lease liabilities 21,602 26,653 Capitalized research and development 9,183 6,372 Other 1,119 651 Total deferred tax assets $ 79,074 $ 76,088 Valuation allowance for deferred tax assets (13,076) (13,088) Net deferred tax assets $ 65,998 $ 63,000 Deferred tax liabilities: Depreciation and amortization $ 3,395 $ 3,574 Right of use asset 19,226 25,744 Acquisition intangibles 7,782 32,315 Other 37 — Total deferred tax liabilities $ 30,440 $ 61,633 Total net deferred tax assets $ 35,558 $ 1,367 |
Reconciliation of Unrecognized Tax Benefits | The following table summarizes the changes in the unrecognized tax benefits (in thousands): March 25, March 26, Beginning balance $ 32,879 $ 32,879 Additions based on tax positions related to the current year — — Reductions based on tax positions related to the prior years — — Ending balance $ 32,879 $ 32,879 |
Segment Information (Tables)
Segment Information (Tables) | 12 Months Ended |
Mar. 25, 2023 | |
Segment Reporting [Abstract] | |
Schedule of Sales by Geographic Location Based on Customer Ship To Location | The following illustrates sales by ship to location of the customer (in thousands): Fiscal Years Ended March 25, March 26, March 27, China $ 1,230,602 $ 1,197,812 $ 1,024,178 Hong Kong 223,405 325,433 170,605 Vietnam 93,760 72,162 10,115 South Korea 93,177 51,606 42,403 India 69,343 18,257 14,481 United States 52,688 29,513 21,708 Rest of World 134,642 86,677 85,740 Total consolidated sales $ 1,897,617 $ 1,781,460 $ 1,369,230 |
Schedule of Property, Plant, and Equipment, Net, by Geographic Location | The following illustrates property, plant and equipment, net, by geographic locations, based on physical location (in thousands): Fiscal Years Ended March 25, March 26, United States $ 132,633 $ 118,847 United Kingdom 20,675 28,612 Rest of World 9,664 9,618 Total consolidated property, plant and equipment, net $ 162,972 $ 157,077 |
Summary of Significant Accoun_4
Summary of Significant Accounting Policies (Narrative) (Details) - USD ($) shares in Thousands, $ in Thousands | 12 Months Ended | ||
Mar. 25, 2023 | Mar. 26, 2022 | Mar. 27, 2021 | |
Inventory Disclosure [Abstract] | |||
Inventory write-down | $ 9,900 | $ 6,500 | |
Property, Plant and Equipment, Net [Abstract] | |||
Equipment disposal charges, net of recovery | 1,300 | ||
Gain on sale of assets | 0 | 0 | $ 0 |
Depreciation and amortization expense on property, plant and equipment | 27,100 | 24,800 | 24,900 |
Intangible Assets, Net (Including Goodwill) [Abstract] | |||
Impairment of goodwill | 0 | 0 | 0 |
Intangibles impairment | 85,760 | 0 | 0 |
Marketing and Advertising Expense [Abstract] | |||
Advertising costs | $ 500 | $ 900 | $ 900 |
Government Assistance [Abstract] | |||
Government Assistance, Statement of Income or Comprehensive Income [Extensible Enumeration] | Research and development | Research and development | |
Earnings Per Share [Abstract] | |||
Weighted outstanding options excluded from diluted calculation (in shares) | 268 | 113 | 187 |
Research and Development Expenditure Credit (“RDEC”) | |||
Government Assistance [Abstract] | |||
Government assistance, amount | $ 26,200 | $ 23,200 | |
Government assistance, amount, cumulative | $ 47,000 | ||
Foxconn | Accounts Receivable | Customer Concentration Risk | |||
Concentration Of Credit Risk [Abstract] | |||
Concentration risk, percentage | 35% | 49% | |
Pegatron | Accounts Receivable | Customer Concentration Risk | |||
Concentration Of Credit Risk [Abstract] | |||
Concentration risk, percentage | 16% | 17% | |
Luxshare Precision | Accounts Receivable | Customer Concentration Risk | |||
Concentration Of Credit Risk [Abstract] | |||
Concentration risk, percentage | 11% | ||
Ten Largest Customers | Sales Revenue, Net | Customer Concentration Risk | |||
Concentration Of Credit Risk [Abstract] | |||
Concentration risk, percentage | 92% | 93% | 93% |
Apple, Inc. | Sales Revenue, Net | Customer Concentration Risk | |||
Concentration Of Credit Risk [Abstract] | |||
Concentration risk, percentage | 83% | 79% | 83% |
Capitalized Software | |||
Property, Plant and Equipment, Net [Abstract] | |||
Estimated useful life | 3 years | ||
Capitalized Enterprise Resource Planning Software | |||
Property, Plant and Equipment, Net [Abstract] | |||
Estimated useful life | 10 years | ||
Minimum | |||
Intangible Assets, Net (Including Goodwill) [Abstract] | |||
Intangible assets, useful life | 1 year | ||
Acquired intangible assets, useful life | 1 year | ||
Contract Balance Payment Terms [Abstract] | |||
Contract balance, payment term | 30 days | ||
Share-based Compensation [Abstract] | |||
Share-based compensation, vesting period | 1 year | ||
Minimum | Property, Plant and Equipment | |||
Property, Plant and Equipment, Net [Abstract] | |||
Estimated useful life | 3 years | ||
Minimum | Furniture, Fixtures, Machinery and Equipment | |||
Property, Plant and Equipment, Net [Abstract] | |||
Estimated useful life | 3 years | ||
Maximum | |||
Intangible Assets, Net (Including Goodwill) [Abstract] | |||
Intangible assets, useful life | 5 years | ||
Acquired intangible assets, useful life | 15 years | ||
Contract Balance Payment Terms [Abstract] | |||
Contract balance, payment term | 60 days | ||
Share-based Compensation [Abstract] | |||
Share-based compensation, vesting period | 4 years | ||
Maximum | Property, Plant and Equipment | |||
Property, Plant and Equipment, Net [Abstract] | |||
Estimated useful life | 39 years | ||
Maximum | Furniture, Fixtures, Machinery and Equipment | |||
Property, Plant and Equipment, Net [Abstract] | |||
Estimated useful life | 10 years | ||
Maximum | Buildings | |||
Property, Plant and Equipment, Net [Abstract] | |||
Estimated useful life | 39 years |
Summary of Significant Accoun_5
Summary of Significant Accounting Policies (Schedule of Inventories) (Details) - USD ($) $ in Thousands | Mar. 25, 2023 | Mar. 26, 2022 |
Accounting Policies [Abstract] | ||
Work in process | $ 116,088 | $ 95,188 |
Finished goods | 117,362 | 43,248 |
Inventories | $ 233,450 | $ 138,436 |
Summary of Significant Accoun_6
Summary of Significant Accounting Policies (Components of Property, Plant and Equipment) (Details) - USD ($) $ in Thousands | Mar. 25, 2023 | Mar. 26, 2022 |
Property, Plant and Equipment [Line Items] | ||
Total property, plant and equipment | $ 397,193 | $ 373,339 |
Less: Accumulated depreciation and amortization | (234,221) | (216,262) |
Property, plant and equipment, net | 162,972 | 157,077 |
Land | ||
Property, Plant and Equipment [Line Items] | ||
Total property, plant and equipment | 23,853 | 23,853 |
Buildings | ||
Property, Plant and Equipment [Line Items] | ||
Total property, plant and equipment | 64,056 | 63,730 |
Furniture and fixtures | ||
Property, Plant and Equipment [Line Items] | ||
Total property, plant and equipment | 23,909 | 24,122 |
Leasehold improvements | ||
Property, Plant and Equipment [Line Items] | ||
Total property, plant and equipment | 55,733 | 53,611 |
Machinery and equipment | ||
Property, Plant and Equipment [Line Items] | ||
Total property, plant and equipment | 188,403 | 175,966 |
Capitalized software | ||
Property, Plant and Equipment [Line Items] | ||
Total property, plant and equipment | 26,889 | 26,491 |
Construction in progress and other | ||
Property, Plant and Equipment [Line Items] | ||
Total property, plant and equipment | $ 14,350 | $ 5,566 |
Summary of Significant Accoun_7
Summary of Significant Accounting Policies (Calculation of Basic and Diluted Earnings Per Share) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 12 Months Ended | ||
Mar. 25, 2023 | Mar. 26, 2022 | Mar. 27, 2021 | |
Numerator: | |||
Net income | $ 176,703 | $ 326,355 | $ 217,344 |
Denominator: | |||
Weighted average shares outstanding (in shares) | 55,614 | 57,278 | 58,106 |
Effect of dilutive securities (in shares) | 1,612 | 1,865 | 1,954 |
Weighted average diluted shares (in shares) | 57,226 | 59,143 | 60,060 |
Basic earnings per share (in dollars per share) | $ 3.18 | $ 5.70 | $ 3.74 |
Diluted earnings per share (in dollars per share) | $ 3.09 | $ 5.52 | $ 3.62 |
Marketable Securities (Schedule
Marketable Securities (Schedule of Available-for-sale Securities) (Details) - USD ($) $ in Thousands | Mar. 25, 2023 | Mar. 26, 2022 |
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | $ 73,376 | $ 76,673 |
Gross Unrealized Gains | 108 | 2 |
Gross Unrealized Losses | (1,997) | (2,325) |
Estimated Fair Value (Net Carrying Amount) | 71,487 | 74,350 |
Corporate debt securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 66,753 | 70,296 |
Gross Unrealized Gains | 91 | 2 |
Gross Unrealized Losses | (1,825) | (2,133) |
Estimated Fair Value (Net Carrying Amount) | 65,019 | 68,165 |
Non-U.S. government securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 510 | 509 |
Gross Unrealized Gains | 0 | 0 |
Gross Unrealized Losses | (3) | (9) |
Estimated Fair Value (Net Carrying Amount) | 507 | 500 |
U.S. Treasury securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 5,728 | 5,483 |
Gross Unrealized Gains | 17 | 0 |
Gross Unrealized Losses | (151) | (169) |
Estimated Fair Value (Net Carrying Amount) | 5,594 | 5,314 |
Agency discount notes | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 385 | 385 |
Gross Unrealized Gains | 0 | 0 |
Gross Unrealized Losses | (18) | (14) |
Estimated Fair Value (Net Carrying Amount) | $ 367 | $ 371 |
Marketable Securities (Narrativ
Marketable Securities (Narrative) (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Mar. 25, 2023 | Mar. 26, 2022 | |
Debt Securities, Available-for-sale [Line Items] | ||
Gross unrealized losses | $ 1,997 | $ 2,325 |
Amortized cost on available for sale securities held at gross unrealized loss | 64,000 | 75,500 |
Securities in a continuous unrealized loss position for more than 12 months, amortized cost | 56,300 | 3,500 |
Securities in a continuous unrealized loss position for more than 12 months, aggregate unrealized loss | $ 1,900 | $ 100 |
Minimum | ||
Debt Securities, Available-for-sale [Line Items] | ||
Maturity period for highly-rated securities | 1 year | |
Maximum | ||
Debt Securities, Available-for-sale [Line Items] | ||
Maturity period for highly-rated securities | 3 years |
Marketable Securities (Schedu_2
Marketable Securities (Schedule of Cost and Estimated Fair Value of Available-for-sale Securities by Contractual Maturity) (Details) - USD ($) $ in Thousands | Mar. 25, 2023 | Mar. 26, 2022 |
Marketable Securities [Abstract] | ||
Within 1 year, Amortized Cost | $ 35,824 | $ 10,697 |
After 1 year, Amortized Cost | 37,552 | 65,976 |
Amortized Cost | 73,376 | 76,673 |
Within 1 year, Estimated Fair Value | 34,978 | 10,601 |
After 1 year, Estimated Fair Value | 36,509 | 63,749 |
Estimated Fair Value (Net Carrying Amount) | $ 71,487 | $ 74,350 |
Fair Value of Financial Instr_3
Fair Value of Financial Instruments (Narrative) (Details) - USD ($) | Mar. 20, 2023 | Mar. 25, 2023 |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Long-term line of credit, noncurrent | $ 0 | |
Long-term revolving facility, fair value | 0 | |
Second Amended Credit Agreement Revolving Credit Facility | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Long-term line of credit, noncurrent | $ 0 | |
Second Amended Credit Agreement Revolving Credit Facility | Secured Overnight Financing Rate (SOFR) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Basis spread on variable interest rate | 0.10% |
Fair Value of Financial Instr_4
Fair Value of Financial Instruments (Schedule of Fair Value of Financial Assets and Liabilities) (Details) - USD ($) $ in Thousands | Mar. 25, 2023 | Mar. 26, 2022 |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash equivalents | $ 217,400 | |
Available-for-sale securities | $ 71,487 | 74,350 |
Quoted Prices in Active Markets for Identical Assets Level 1 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash equivalents | 217,151 | |
Available-for-sale securities | 5,594 | 5,314 |
Significant Other Observable Inputs Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash equivalents | 249 | |
Available-for-sale securities | 65,893 | 69,036 |
Significant Unobservable Inputs Level 3 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash equivalents | 0 | |
Available-for-sale securities | 0 | 0 |
Corporate debt securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale securities | 65,019 | 68,165 |
Corporate debt securities | Quoted Prices in Active Markets for Identical Assets Level 1 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale securities | 0 | 0 |
Corporate debt securities | Significant Other Observable Inputs Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale securities | 65,019 | 68,165 |
Corporate debt securities | Significant Unobservable Inputs Level 3 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale securities | 0 | 0 |
Non-U.S. government securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale securities | 507 | 500 |
Non-U.S. government securities | Quoted Prices in Active Markets for Identical Assets Level 1 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale securities | 0 | 0 |
Non-U.S. government securities | Significant Other Observable Inputs Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale securities | 507 | 500 |
Non-U.S. government securities | Significant Unobservable Inputs Level 3 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale securities | 0 | 0 |
U.S. Treasury securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale securities | 5,594 | 5,314 |
U.S. Treasury securities | Quoted Prices in Active Markets for Identical Assets Level 1 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale securities | 5,594 | 5,314 |
U.S. Treasury securities | Significant Other Observable Inputs Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale securities | 0 | 0 |
U.S. Treasury securities | Significant Unobservable Inputs Level 3 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale securities | 0 | 0 |
Agency discount notes | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale securities | 367 | 371 |
Agency discount notes | Quoted Prices in Active Markets for Identical Assets Level 1 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale securities | 0 | 0 |
Agency discount notes | Significant Other Observable Inputs Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale securities | 367 | 371 |
Agency discount notes | Significant Unobservable Inputs Level 3 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale securities | 0 | 0 |
Money market funds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash equivalents | 406,265 | 217,151 |
Money market funds | Quoted Prices in Active Markets for Identical Assets Level 1 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash equivalents | 406,265 | 217,151 |
Money market funds | Significant Other Observable Inputs Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash equivalents | 0 | 0 |
Money market funds | Significant Unobservable Inputs Level 3 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash equivalents | $ 0 | 0 |
Commercial paper | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash equivalents | 249 | |
Commercial paper | Quoted Prices in Active Markets for Identical Assets Level 1 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash equivalents | 0 | |
Commercial paper | Significant Other Observable Inputs Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash equivalents | 249 | |
Commercial paper | Significant Unobservable Inputs Level 3 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash equivalents | $ 0 |
Derivative Financial Instrume_3
Derivative Financial Instruments (Details) $ in Thousands | 12 Months Ended | ||
Mar. 25, 2023 USD ($) derivtive | Mar. 26, 2022 USD ($) | Mar. 27, 2021 USD ($) | |
Derivative Instruments, Gain (Loss) [Line Items] | |||
Number of foreign currency derivatives held | derivtive | 1 | ||
Notional value of foreign currency forward contract | $ 7,600 | ||
Foreign currency forward contracts | Not Designated as Hedging Instrument | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Gain (loss) recognized in income, foreign currency forward contracts | $ (564) | $ (283) | $ 3,212 |
Accounts Receivable, net (Compo
Accounts Receivable, net (Components of Accounts Receivable, Net) (Details) - USD ($) $ in Thousands | Mar. 25, 2023 | Mar. 26, 2022 |
Accounts Receivable, after Allowance for Credit Loss [Abstract] | ||
Gross accounts receivable | $ 150,473 | $ 240,264 |
Allowance for doubtful accounts | 0 | 0 |
Accounts receivable, net | $ 150,473 | $ 240,264 |
Intangibles, net and Goodwill_2
Intangibles, net and Goodwill (Narrative) (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Mar. 25, 2023 | Mar. 26, 2022 | Mar. 27, 2021 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |||
Intangibles impairment | $ 85,760 | $ 0 | $ 0 |
Amortization expense for intangibles | 33,700 | 29,000 | $ 14,500 |
Goodwill | $ 435,936 | $ 435,791 |
Intangibles, net and Goodwill_3
Intangibles, net and Goodwill (Schedule of Gross Carrying Amount and Amortization of Intangible Assets) (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Mar. 25, 2023 | Mar. 26, 2022 | |
Finite-Lived Intangible Assets [Line Items] | ||
Gross Amount | $ 258,990 | $ 386,435 |
Accumulated Amortization | (220,114) | (228,290) |
Net Carrying Value | $ 38,876 | 158,145 |
Existing technology | ||
Finite-Lived Intangible Assets [Line Items] | ||
Weighted-average amortization period | 5 years 3 months 18 days | |
Gross Amount | $ 146,146 | 255,995 |
Accumulated Amortization | (110,792) | (124,127) |
Net Carrying Value | 35,354 | 131,868 |
In-process research & development (“IPR&D”) | ||
Finite-Lived Intangible Assets [Line Items] | ||
Gross Amount | 70,936 | 70,936 |
Accumulated Amortization | (70,936) | (67,486) |
Net Carrying Value | $ 0 | 3,450 |
Trademarks and tradename | ||
Finite-Lived Intangible Assets [Line Items] | ||
Weighted-average amortization period | 6 months | |
Gross Amount | $ 3,037 | 3,037 |
Accumulated Amortization | (2,973) | (2,845) |
Net Carrying Value | $ 64 | 192 |
Customer Relationships | ||
Finite-Lived Intangible Assets [Line Items] | ||
Weighted-average amortization period | 1 year 4 months 24 days | |
Gross Amount | $ 15,381 | 34,091 |
Accumulated Amortization | (13,422) | (14,379) |
Net Carrying Value | $ 1,959 | 19,712 |
Technology licenses | ||
Finite-Lived Intangible Assets [Line Items] | ||
Weighted-average amortization period | 1 year 8 months 12 days | |
Gross Amount | $ 23,490 | 22,376 |
Accumulated Amortization | (21,991) | (19,453) |
Net Carrying Value | $ 1,499 | $ 2,923 |
Intangibles, net and Goodwill_4
Intangibles, net and Goodwill (Schedule of Estimated Aggregate Amortization Expense for Intangibles) (Details) $ in Thousands | Mar. 25, 2023 USD ($) |
Goodwill and Intangible Assets Disclosure [Abstract] | |
2024 | $ 9,221 |
2025 | 7,600 |
2026 | 6,681 |
2027 | 6,589 |
2028 | 6,589 |
Thereafter | $ 2,196 |
Acquisition - Narrative (Detail
Acquisition - Narrative (Details) - Lion Semiconductor, Inc. - USD ($) $ in Millions | 3 Months Ended | ||
Jul. 20, 2021 | Dec. 25, 2021 | Mar. 25, 2023 | |
Business Acquisition [Line Items] | |||
Outstanding share capital | 100% | ||
Total consideration transferred | $ 280.5 | ||
Cash acquired | 4.9 | ||
Consideration paid | $ 1.2 | ||
Additional merger consideration subject to indemnity and adjustment provisions | $ 31 | ||
Merger consideration - retention | $ 25.4 |
Revolving Credit Facility (Deta
Revolving Credit Facility (Details) - USD ($) | Mar. 20, 2023 | Jul. 08, 2021 | Mar. 25, 2023 |
Line of Credit Facility [Line Items] | |||
Long-term line of credit, noncurrent | $ 0 | ||
Second Amended Credit Agreement Revolving Credit Facility | |||
Line of Credit Facility [Line Items] | |||
Line of credit facility maximum borrowing capacity | $ 300,000,000 | ||
Debt covenant, exclusion of unrestricted cash and cash equivalents for ratio of consolidated funded indebtedness | $ 200,000,000 | ||
Debt covenant, maximum consolidated net leverage ratio | 3 | ||
Debt covenant, minimum consolidated interest coverage ratio | 3 | ||
Long-term line of credit, noncurrent | $ 0 | ||
Second Amended Credit Agreement Revolving Credit Facility | Minimum | |||
Line of Credit Facility [Line Items] | |||
Line of credit facility, unused capacity, commitment fee percentage | 0.175% | ||
Second Amended Credit Agreement Revolving Credit Facility | Maximum | |||
Line of Credit Facility [Line Items] | |||
Line of credit facility, unused capacity, commitment fee percentage | 0.275% | ||
Second Amended Credit Agreement Revolving Credit Facility | Base Rate | Minimum | |||
Line of Credit Facility [Line Items] | |||
Basis spread on variable interest rate | 0% | ||
Second Amended Credit Agreement Revolving Credit Facility | Base Rate | Maximum | |||
Line of Credit Facility [Line Items] | |||
Basis spread on variable interest rate | 0.75% | ||
Second Amended Credit Agreement Revolving Credit Facility | Secured Overnight Financing Rate (SOFR) | |||
Line of Credit Facility [Line Items] | |||
Basis spread on variable interest rate | 0.10% | ||
Second Amended Credit Agreement Revolving Credit Facility | Secured Overnight Financing Rate (SOFR) | Minimum | |||
Line of Credit Facility [Line Items] | |||
Basis spread on variable interest rate | 1% | ||
Second Amended Credit Agreement Revolving Credit Facility | Secured Overnight Financing Rate (SOFR) | Maximum | |||
Line of Credit Facility [Line Items] | |||
Basis spread on variable interest rate | 1.75% |
Revolving Credit Facility - Fut
Revolving Credit Facility - Future Interest Payment Obligations (Details) $ in Thousands | Mar. 25, 2023 USD ($) |
Future Interest Payment Obligations [Roll Forward] | |
2024 | $ 528 |
2025 | 534 |
2026 | 532 |
2027 | 277 |
2028 | 0 |
Thereafter | 0 |
Total | $ 1,871 |
Revenues - Product Line Disaggr
Revenues - Product Line Disaggregation of Revenue (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Mar. 25, 2023 | Mar. 26, 2022 | Mar. 27, 2021 | |
Disaggregation of Revenue [Line Items] | |||
Net sales | $ 1,897,617 | $ 1,781,460 | $ 1,369,230 |
Audio Products | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 1,172,007 | 1,187,126 | 1,104,060 |
HPMS Products | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | $ 725,610 | $ 594,334 | $ 265,170 |
Revenues - Geographic Disaggreg
Revenues - Geographic Disaggregation of Revenue (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Mar. 25, 2023 | Mar. 26, 2022 | Mar. 27, 2021 | |
Disaggregation of Revenue [Line Items] | |||
Net sales | $ 1,897,617 | $ 1,781,460 | $ 1,369,230 |
China | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 1,230,602 | 1,197,812 | 1,024,178 |
United States | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 52,688 | 29,513 | 21,708 |
Rest of World | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | $ 614,327 | $ 554,135 | $ 323,344 |
Leases (Narrative) (Details)
Leases (Narrative) (Details) $ in Millions | Mar. 25, 2023 USD ($) |
Lessee, Lease, Description [Line Items] | |
Operating lease undiscounted amount | $ 24 |
Operating lease term of contract | 10 years |
Minimum | |
Lessee, Lease, Description [Line Items] | |
Lease term | 1 year |
Maximum | |
Lessee, Lease, Description [Line Items] | |
Lease term | 26 years |
Leases (Schedule of Lease Expen
Leases (Schedule of Lease Expense, Lease Income, and Other Information) (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Mar. 25, 2023 | Mar. 26, 2022 | |
Leases [Abstract] | ||
Operating lease - in excess of 12 months | $ 18,071 | $ 14,901 |
Variable lease | 6,226 | 4,954 |
Short-term lease | 86 | 22 |
Operating lease income | (464) | (1,518) |
Total net operating lease expense | $ 23,919 | $ 18,359 |
Operating Lease Income Comprehensive Income Extensible List Not Disclosed Flag | Operating lease income | Operating lease income |
Balance Sheet Information (in thousands) | ||
Operating lease right-of-use assets | $ 128,145 | $ 171,003 |
Operating lease liabilities | 141,073 | 177,842 |
Cash Flow Information (in thousands) | ||
Operating cash flows from operating leases | 14,531 | 14,634 |
Non-Cash Information | ||
Right-of-use assets obtained in exchange for new operating lease liabilities | 4,381 | 46,123 |
Lease remeasurements | (28,965) | 0 |
Lease impairments | $ (5,579) | $ 0 |
Operating Lease Information | ||
Weighted-average remaining lease term - operating leases (in years) | 13 years | 16 years |
Weighted-average discount rate - operating leases | 4% | 4% |
Leases (Schedule of Future Leas
Leases (Schedule of Future Lease Commitments) (Details) - USD ($) $ in Thousands | Mar. 25, 2023 | Mar. 26, 2022 |
Operating Lease Expense | ||
2024 | $ 18,631 | |
2025 | 19,598 | |
2026 | 18,043 | |
2027 | 16,489 | |
2028 | 16,882 | |
Thereafter | 106,651 | |
Total | 196,294 | |
Less imputed interest and other | (55,221) | |
Total | $ 141,073 | $ 177,842 |
Leases (Schedule of Lease Liabi
Leases (Schedule of Lease Liabilities) (Details) - USD ($) $ in Thousands | Mar. 25, 2023 | Mar. 26, 2022 |
Leases [Abstract] | ||
Current lease liabilities | $ 18,442 | $ 14,680 |
Non-current lease liabilities | 122,631 | 163,162 |
Total operating lease liabilities | $ 141,073 | $ 177,842 |
Lease Impairments and Restruc_2
Lease Impairments and Restructuring (Narrative) (Details) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended | ||
Mar. 25, 2023 | Mar. 25, 2023 | Mar. 26, 2022 | Mar. 27, 2021 | |
Restructuring and Related Activities [Abstract] | ||||
Lease impairments and restructuring | $ 10,632 | $ 0 | $ 352 | |
Impairment of right-of-use assets and leasehold improvements | $ 6,900 | |||
Other related charges | 3,700 | |||
Accrued restructuring charges | $ 3,300 | $ 3,300 | $ 0 |
Postretirement Benefit Plans (N
Postretirement Benefit Plans (Narrative) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Mar. 25, 2023 | Mar. 26, 2022 | Mar. 27, 2021 | |
Retirement Benefits [Abstract] | |||
Employee matching contribution | $ 10.2 | $ 9.6 | $ 7.9 |
Equity Compensation (Narrative)
Equity Compensation (Narrative) (Details) $ / shares in Units, shares in Thousands, $ in Thousands | 12 Months Ended | ||
Mar. 25, 2023 USD ($) $ / shares shares | Mar. 26, 2022 USD ($) $ / shares shares | Mar. 27, 2021 USD ($) $ / shares shares | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Shares available for grant reduction ratio | 1.5 | ||
Stock-based compensation expense | $ 81,641 | $ 66,392 | $ 56,762 |
Excess tax benefits, amount | 1,400 | 3,900 | 2,200 |
Net amount received from exercise of stock options granted | $ 10,100 | $ 13,200 | $ 7,100 |
Options exercised (in shares) | shares | 225 | 327 | 236 |
Total intrinsic value of stock options exercised | $ 11,400 | $ 15,800 | $ 10,200 |
Fair value of options that became vested during the period | $ 3,000 | $ 4,600 | $ 4,800 |
Number of options exercisable (in shares) | shares | 452 | 600 | 700 |
Weighted Average Estimated Fair Value Using Black-Scholes Option Valuation Model | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Fair value of stock options granted under the Black-Scholes valuation model (in dollars per share) | $ / shares | $ 42.37 | $ 37.31 | $ 33.81 |
Employee Stock Option | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Compensation costs related to equity incentive plans, weighted average recognition period | 1 year 7 months 9 days | ||
Restricted Stock Units (RSUs) | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Compensation costs related to equity incentive plans, weighted average recognition period | 1 year 7 months 13 days | ||
Vesting percentage | 100% | ||
Intrinsic value of awards outstanding | $ 326,300 | $ 225,900 | $ 216,900 |
Fair value of awards vested | $ 61,400 | $ 41,100 | $ 46,700 |
Shares vested (in shares) | shares | 877 | 935 | 881 |
Shares withheld to satisfy tax withholding requirements (in shares) | shares | 200 | 300 | 300 |
Payment to taxing authorities | $ 18,000 | $ 22,000 | $ 18,400 |
Weighted averaged estimated fair value of awards granted (in dollars per share) | $ / shares | $ 75.97 | $ 81.61 | $ 71.44 |
Market Stock Unit (MSUs) | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Share-based compensation, vesting period | 3 years | ||
Compensation costs related to equity incentive plans, weighted average recognition period | 2 years 7 days | ||
Intrinsic value of awards outstanding | $ 9,300 | $ 7,500 | $ 11,000 |
Fair value of awards vested | $ 800 | $ 1,500 | $ 0 |
Shares vested (in shares) | shares | 10 | 30 | 0 |
Weighted averaged estimated fair value of awards granted (in dollars per share) | $ / shares | $ 135.87 | $ 109.18 | $ 83.96 |
Market Stock Unit (MSUs) | Weighted Average Estimated Fair Value Using Monte Carlo Simulation Model | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Weighted averaged estimated fair value of awards granted (in dollars per share) | $ / shares | $ 135.87 | ||
RSUs and MSUs | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Stock-based compensation expense | $ 78,000 | $ 63,200 | $ 53,600 |
Options RSUs and MSUs | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Compensation costs related to equity incentive plans not yet recognized | $ 155,300 | ||
Minimum | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Share-based compensation, vesting period | 1 year | ||
Minimum | Employee Stock Option | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Share-based compensation, vesting period | 1 year | ||
Minimum | Restricted Stock Units (RSUs) | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Share-based compensation, vesting period | 1 year | ||
Maximum | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Share-based compensation, vesting period | 4 years | ||
Maximum | Employee Stock Option | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Share-based compensation, vesting period | 4 years | ||
Share based compensation, period from grant date options are exercisable | 10 years | ||
Maximum | Restricted Stock Units (RSUs) | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Share-based compensation, vesting period | 3 years |
Equity Compensation (Summary of
Equity Compensation (Summary of Activity in Total Stock Available for Grant) (Details) - shares shares in Thousands | 12 Months Ended | ||
Mar. 25, 2023 | Mar. 26, 2022 | Mar. 27, 2021 | |
Share-Based Payment Arrangement, Noncash Expense [Abstract] | |||
Shares available for grant, beginning balance (in shares) | 2,617 | 4,025 | 2,095 |
Shares available for grant, shares added (in shares) | 2,090 | 0 | 3,223 |
Shares available for grant, granted (in shares) | (2,536) | (1,679) | (1,491) |
Shares available for grant, forfeited (in shares) | 303 | 271 | 198 |
Shares available for grant, ending balance (in shares) | 2,474 | 2,617 | 4,025 |
Equity Compensation (Summary _2
Equity Compensation (Summary of Effect of Stock-Based Compensation) (Details) - USD ($) $ / shares in Units, $ in Thousands | 12 Months Ended | ||
Mar. 25, 2023 | Mar. 26, 2022 | Mar. 27, 2021 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Effect on pre-tax income | $ 81,641 | $ 66,392 | $ 56,762 |
Income Tax Benefit | (15,184) | (11,521) | (9,558) |
Total stock-based compensation expense (net of taxes) | $ 66,457 | $ 54,871 | $ 47,204 |
Share based compensation effects on basic earnings per share (in dollars per share) | $ 1.19 | $ 0.96 | $ 0.81 |
Share based compensation effects on diluted earnings per share (in dollars per share) | $ 1.16 | $ 0.93 | $ 0.79 |
Cost of sales | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Effect on pre-tax income | $ 1,270 | $ 1,024 | $ 900 |
Research and development | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Effect on pre-tax income | 57,312 | 44,154 | 37,483 |
Sales, general and administrative | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Effect on pre-tax income | $ 23,059 | $ 21,214 | $ 18,379 |
Equity Compensation (Schedule o
Equity Compensation (Schedule of Fair Value of Stock Option Grants) (Details) - Employee Stock Option | 12 Months Ended | ||
Mar. 25, 2023 | Mar. 26, 2022 | Mar. 27, 2021 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Dividend yield | 0% | ||
Minimum | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Expected stock price volatility | 35.18% | 36.85% | 43.85% |
Risk-free interest rate | 2.47% | 0.82% | 0.35% |
Expected term (in years) | 4 years 14 days | 4 years 2 months 19 days | 4 years 3 months 25 days |
Maximum | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Expected stock price volatility | 46.50% | 41.66% | 43.99% |
Risk-free interest rate | 3.96% | 1.62% | 0.72% |
Expected term (in years) | 4 years 3 months 29 days | 4 years 4 months 20 days | 4 years 5 months 4 days |
Equity Compensation (Schedule_2
Equity Compensation (Schedule of Stock Option Activity) (Details) - $ / shares shares in Thousands | 12 Months Ended | ||
Mar. 25, 2023 | Mar. 26, 2022 | Mar. 27, 2021 | |
Number | |||
Beginning balance (in shares) | 820 | 1,059 | 1,216 |
Options granted (in shares) | 143 | 88 | 96 |
Options exercised (in shares) | (225) | (327) | (236) |
Options forfeited (in shares) | (18) | 0 | (17) |
Options expired (in shares) | 0 | 0 | 0 |
Ending balance (in shares) | 720 | 820 | 1,059 |
Weighted Average Exercise Price | |||
Beginning balance (in dollars per share) | $ 57.75 | $ 49.87 | $ 44.01 |
Options granted (in dollars per share) | 96.33 | 87.52 | 77.23 |
Options exercised (in dollars per share) | 45.10 | 40.31 | 30.26 |
Options forfeited (in dollars per share) | 71.14 | 0 | 56.27 |
Options expired (in dollars per share) | 0 | 0 | 0 |
Ending balance (in dollars per share) | $ 69.03 | $ 57.75 | $ 49.87 |
Equity Compensation (Summary _3
Equity Compensation (Summary of Outstanding Options Vesting, Expected to Vest, or Exercisable) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 12 Months Ended | ||
Mar. 25, 2023 | Mar. 26, 2022 | Mar. 27, 2021 | |
Share-Based Payment Arrangement, Noncash Expense [Abstract] | |||
Number of Options, Vested and expected to vest (in shares) | 709 | ||
Weighted Average Exercise Price, Vested and expected to vest (in dollars per share) | $ 68.63 | ||
Weighted Average Remaining Contractual Term, Vested and expected to vest | 6 years 8 months 1 day | ||
Aggregate Intrinsic Value, Vested and expected to vest | $ 26,208 | ||
Number of Options, Exercisable (in shares) | 452 | 600 | 700 |
Weighted Average Exercise Price, Exercisable (in dollars per share) | $ 57.01 | ||
Weighted Average Remaining Contractual Term, Exercisable | 5 years 4 months 13 days | ||
Aggregate Intrinsic Value, Exercisable | $ 21,955 |
Equity Compensation (Summary _4
Equity Compensation (Summary of Outstanding and Exercisable Options) (Details) shares in Thousands | 12 Months Ended |
Mar. 25, 2023 $ / shares shares | |
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items] | |
Options Outstanding, Number (in shares) | shares | 720 |
Options Outstanding, Weighted Average Remaining Contractual Life | 6 years 8 months 15 days |
Options Outstanding, Weighted Average Exercise Price (in dollars per share) | $ 69.03 |
Options Exercisable, Number Exercisable (in shares) | shares | 452 |
Options Exercisable, Weighted Average Exercise Price (in dollars per share) | $ 57.01 |
$20.37 - $54.65 (in dollars per share) | |
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items] | |
Range of Exercise Prices, lower limit (in dollars per share) | 20.37 |
Range of Exercise Prices, upper limit (in dollars per share) | $ 54.65 |
Options Outstanding, Number (in shares) | shares | 200 |
Options Outstanding, Weighted Average Remaining Contractual Life | 4 years 3 months 18 days |
Options Outstanding, Weighted Average Exercise Price (in dollars per share) | $ 45.06 |
Options Exercisable, Number Exercisable (in shares) | shares | 200 |
Options Exercisable, Weighted Average Exercise Price (in dollars per share) | $ 45.06 |
$55.72 - $68.56 (in dollars per share) | |
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items] | |
Range of Exercise Prices, lower limit (in dollars per share) | 55.72 |
Range of Exercise Prices, upper limit (in dollars per share) | $ 68.56 |
Options Outstanding, Number (in shares) | shares | 215 |
Options Outstanding, Weighted Average Remaining Contractual Life | 5 years 8 months 12 days |
Options Outstanding, Weighted Average Exercise Price (in dollars per share) | $ 62.55 |
Options Exercisable, Number Exercisable (in shares) | shares | 193 |
Options Exercisable, Weighted Average Exercise Price (in dollars per share) | $ 61.83 |
$78 - $82.14 (in dollars per share) | |
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items] | |
Range of Exercise Prices, lower limit (in dollars per share) | 78 |
Range of Exercise Prices, upper limit (in dollars per share) | $ 82.14 |
Options Outstanding, Number (in shares) | shares | 100 |
Options Outstanding, Weighted Average Remaining Contractual Life | 8 years 2 months 12 days |
Options Outstanding, Weighted Average Exercise Price (in dollars per share) | $ 78.53 |
Options Exercisable, Number Exercisable (in shares) | shares | 39 |
Options Exercisable, Weighted Average Exercise Price (in dollars per share) | $ 78.27 |
$82.81 - $82.81 (in dollars per share) | |
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items] | |
Range of Exercise Prices, lower limit (in dollars per share) | 82.81 |
Range of Exercise Prices, upper limit (in dollars per share) | $ 82.81 |
Options Outstanding, Number (in shares) | shares | 21 |
Options Outstanding, Weighted Average Remaining Contractual Life | 9 years 1 month 9 days |
Options Outstanding, Weighted Average Exercise Price (in dollars per share) | $ 82.81 |
Options Exercisable, Number Exercisable (in shares) | shares | 0 |
Options Exercisable, Weighted Average Exercise Price (in dollars per share) | $ 0 |
$88 - $88 (in dollars per share) | |
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items] | |
Range of Exercise Prices, lower limit (in dollars per share) | 88 |
Range of Exercise Prices, upper limit (in dollars per share) | $ 88 |
Options Outstanding, Number (in shares) | shares | 81 |
Options Outstanding, Weighted Average Remaining Contractual Life | 8 years 11 months 8 days |
Options Outstanding, Weighted Average Exercise Price (in dollars per share) | $ 88 |
Options Exercisable, Number Exercisable (in shares) | shares | 20 |
Options Exercisable, Weighted Average Exercise Price (in dollars per share) | $ 88 |
$102.37- $102.37 (in dollars per share) | |
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items] | |
Range of Exercise Prices, lower limit (in dollars per share) | 102.37 |
Range of Exercise Prices, upper limit (in dollars per share) | $ 102.37 |
Options Outstanding, Number (in shares) | shares | 103 |
Options Outstanding, Weighted Average Remaining Contractual Life | 9 years 10 months 13 days |
Options Outstanding, Weighted Average Exercise Price (in dollars per share) | $ 102.37 |
Options Exercisable, Number Exercisable (in shares) | shares | 0 |
Options Exercisable, Weighted Average Exercise Price (in dollars per share) | $ 0 |
Equity Compensation (Summary _5
Equity Compensation (Summary of Restricted Stock Unit Activity) (Details) - Restricted Stock Units (RSUs) - $ / shares shares in Thousands | 12 Months Ended | ||
Mar. 25, 2023 | Mar. 26, 2022 | Mar. 27, 2021 | |
Shares | |||
Beginning balance (in shares) | 2,576 | 2,613 | 2,680 |
Granted (in shares) | 1,574 | 1,079 | 945 |
Vested (in shares) | (877) | (935) | (881) |
Forfeited (in shares) | (183) | (181) | (131) |
Ending balance (in shares) | 3,090 | 2,576 | 2,613 |
Weighted Average Fair Value | |||
Beginning balance (in dollars per share) | $ 74.45 | $ 60.31 | $ 53.74 |
Granted (in dollars per share) | 75.97 | 81.61 | 71.44 |
Vested (in dollars per share) | 70.02 | 43.96 | 52.97 |
Forfeited (in dollars per share) | 75.58 | 70.60 | 55.36 |
Ending balance (in dollars per share) | $ 76.42 | $ 74.45 | $ 60.31 |
Equity Compensation (Summary _6
Equity Compensation (Summary of Restricted Stock Units Expected to Vest) (Details) - Restricted Stock Units (RSUs) shares in Thousands | 12 Months Ended |
Mar. 25, 2023 $ / shares shares | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Shares, expected to vest (in shares) | shares | 2,896 |
Weighted Average Fair Value, expected to vest (in dollars per share) | $ / shares | $ 76.42 |
Weighted Average Remaining Contractual Term, expected to vest | 1 year 7 months 6 days |
Equity Compensation (Schedule_3
Equity Compensation (Schedule of Fair Value Market Stock Units Assumptions) (Details) | 12 Months Ended | ||
Mar. 25, 2023 | Mar. 26, 2022 | Mar. 27, 2021 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Expected stock price, minimum | 35.18% | ||
Expected stock price, maximum | 46.50% | ||
Risk free interest rate, minimum | 2.67% | ||
Risk free interest rate, maximum | 3.92% | ||
Market Stock Unit (MSUs) | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Dividend yield | 0% | ||
Expected stock price volatility | 41.66% | ||
Risk-free interest rate | 1.46% | ||
Expected term (in years) | 3 years | 3 years | 3 years |
Maximum | Market Stock Unit (MSUs) | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Expected stock price volatility | 43.85% | ||
Risk-free interest rate | 0.29% |
Equity Compensation (Summary _7
Equity Compensation (Summary of Market Stock Unit Activity) (Details) - Market Stock Unit (MSUs) - $ / shares shares in Thousands | 12 Months Ended | ||
Mar. 25, 2023 | Mar. 26, 2022 | Mar. 27, 2021 | |
Shares | |||
Beginning balance (in shares) | 85 | 133 | 153 |
Granted (in shares) | 38 | 28 | 28 |
Vested (in shares) | (10) | (30) | 0 |
Forfeited (in shares) | (24) | (46) | (48) |
Ending balance (in shares) | 89 | 85 | 133 |
Weighted Average Fair Value | |||
Beginning balance (in dollars per share) | $ 95.75 | $ 73.29 | $ 68.71 |
Granted (in dollars per share) | 135.87 | 109.18 | 83.96 |
Vested (in dollars per share) | 87.43 | 50.11 | 0 |
Forfeited (in dollars per share) | 94.80 | 38.70 | 64.92 |
Ending balance (in dollars per share) | $ 113.83 | $ 95.75 | $ 73.29 |
Equity Compensation (Summary _8
Equity Compensation (Summary of Market Stock Units Expected to Vest) (Details) - Market Stock Unit (MSUs) shares in Thousands | 12 Months Ended |
Mar. 25, 2023 $ / shares shares | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Shares, expected to vest (in shares) | shares | 82 |
Weighted Average Fair Value, expected to vest (in dollars per share) | $ / shares | $ 113.13 |
Weighted Average Remaining Contractual Term, expected to vest | 2 years |
Commitments and Contingencies -
Commitments and Contingencies - Narrative (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Mar. 25, 2023 | Mar. 26, 2022 | Mar. 27, 2021 | |
Commitments [Line Items] | |||
Rent expense | $ 24,400 | $ 19,900 | $ 19,200 |
Rental income | 500 | $ 1,500 | $ 1,400 |
Capacity reservation fee | 60,000 | ||
Amount agreed to pre-pay | 195,000 | ||
Purchase obligation | 1,365,455 | ||
Minimum | |||
Commitments [Line Items] | |||
Purchase obligation | $ 1,200,000 |
Commitments and Contingencies_2
Commitments and Contingencies - Purchase Commitments (Details) $ in Thousands | Mar. 25, 2023 USD ($) |
Purchase Obligation, Fiscal Year Maturity [Abstract] | |
2024 | $ 563,177 |
2025 | 379,973 |
2026 | 255,222 |
2027 | 164,425 |
2028 | 2,658 |
Thereafter | 0 |
Total | $ 1,365,455 |
Stockholders' Equity (Details)
Stockholders' Equity (Details) - USD ($) $ / shares in Units, $ in Thousands | 12 Months Ended | 27 Months Ended | ||||
Mar. 25, 2023 | Mar. 26, 2022 | Mar. 27, 2021 | Mar. 25, 2023 | Jul. 31, 2022 | Jan. 31, 2021 | |
Equity, Class of Treasury Stock [Line Items] | ||||||
Repurchase and retirement of common stock, value | $ 191,383 | $ 167,501 | $ 109,986 | |||
Repurchase and retirement of common stock (in shares) | 2,400,000 | |||||
Average cost per share repurchased (in dollars per share) | $ 81.16 | |||||
Preferred stock, shares authorized (in shares) | 5,000,000 | 5,000,000 | 5,000,000 | |||
Preferred stock, shares issued (in shares) | 0 | 0 | ||||
January 2021 Repurchase Authorization | ||||||
Equity, Class of Treasury Stock [Line Items] | ||||||
Share repurchase authorization, amount approved | $ 350,000 | |||||
Repurchase and retirement of common stock, value | $ 348,900 | |||||
Share repurchase authorization, remaining authorized repurchase amount | $ 1,100 | $ 1,100 | ||||
July 2022 Repurchase Authorization | ||||||
Equity, Class of Treasury Stock [Line Items] | ||||||
Share repurchase authorization, amount approved | $ 500,000 | |||||
Repurchase and retirement of common stock (in shares) | 0 |
Accumulated Other Comprehensi_3
Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Mar. 25, 2023 | Mar. 26, 2022 | Mar. 27, 2021 | |
AOCI Attributable to Parent, Net of Tax [Roll Forward] | |||
Balance | $ 1,599,817 | $ 1,389,005 | $ 1,229,779 |
Current period foreign exchange translation | (834) | (507) | 1,862 |
Current period marketable securities activity | 430 | (5,587) | 5,673 |
Balance | 1,658,282 | 1,599,817 | 1,389,005 |
Foreign Currency | |||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | |||
Balance | (213) | 294 | |
Current period foreign exchange translation | (834) | (507) | |
Current period marketable securities activity | 0 | 0 | |
Tax effect | 0 | 0 | |
Balance | (1,047) | (213) | 294 |
Unrealized Gains (Losses) on Securities | |||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | |||
Balance | (1,575) | 2,838 | |
Current period foreign exchange translation | 0 | 0 | |
Current period marketable securities activity | 430 | (5,587) | |
Tax effect | (90) | 1,174 | |
Balance | (1,235) | (1,575) | 2,838 |
Accumulated Other Comprehensive Income / (Loss) | |||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | |||
Balance | (2,045) | 2,875 | (3,469) |
Current period foreign exchange translation | (834) | (507) | |
Current period marketable securities activity | 430 | (5,587) | |
Tax effect | (90) | 1,174 | |
Cumulative effect of adoption of ASU 2018-02 | (257) | (257) | (257) |
Balance | $ (2,539) | $ (2,045) | $ 2,875 |
Income Taxes (Summary of Income
Income Taxes (Summary of Income Before Income Taxes) (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Mar. 25, 2023 | Mar. 26, 2022 | Mar. 27, 2021 | |
Income Tax Disclosure [Abstract] | |||
U.S. | $ (141,670) | $ (17,674) | $ 19,189 |
Non-U.S. | 396,409 | 386,337 | 226,057 |
Income before income taxes | $ 254,739 | $ 368,663 | $ 245,246 |
Income Taxes (Summary of Provis
Income Taxes (Summary of Provision (Benefit) for Income Taxes) (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Mar. 25, 2023 | Mar. 26, 2022 | Mar. 27, 2021 | |
Income Taxes [Line Items] | |||
Total current tax provision | $ 112,626 | $ 57,403 | $ 33,409 |
Total deferred tax provision | (34,590) | (15,095) | (5,507) |
Total tax provision | 78,036 | 42,308 | 27,902 |
U.S. | |||
Income Taxes [Line Items] | |||
Total current tax provision | 60,603 | 4,483 | 981 |
Total deferred tax provision | (28,529) | (6,256) | (192) |
Non-U.S. | |||
Income Taxes [Line Items] | |||
Total current tax provision | 52,023 | 52,920 | 32,428 |
Total deferred tax provision | $ (6,061) | $ (8,839) | $ (5,315) |
Income Taxes (Summary of Prov_2
Income Taxes (Summary of Provision (Benefit) for Income Taxes, Statutory Federal Rate Pretax Income Reconciliation) (Details) | 12 Months Ended | ||
Mar. 25, 2023 | Mar. 26, 2022 | Mar. 27, 2021 | |
Income Tax Disclosure [Abstract] | |||
U.S. federal statutory rate | 21% | 21% | 21% |
Foreign income taxed at different rates | (14.40%) | (9.60%) | (8.40%) |
Stock-based compensation | (0.30%) | (0.90%) | (0.80%) |
Foreign-derived intangible income deduction | 0% | (0.10%) | (0.30%) |
GILTI and Subpart F income | 30.60% | 10% | 7.80% |
Foreign tax credits | (7.70%) | (9.40%) | (7.40%) |
Change in valuation allowance | 0.20% | (0.20%) | 0% |
Release of prior year unrecognized tax benefits | 0% | 0% | (1.40%) |
Interest related to unrecognized tax benefits | 0.70% | 0.20% | 0.30% |
Other | 0.50% | 0.50% | 0.60% |
Effective tax rate | 30.60% | 11.50% | 11.40% |
Income Taxes (Narrative) (Detai
Income Taxes (Narrative) (Details) - USD ($) $ in Thousands | 12 Months Ended | |||
May 17, 2022 | Mar. 25, 2023 | Mar. 26, 2022 | Mar. 27, 2021 | |
Income Taxes [Line Items] | ||||
Provision for one-time transition tax liability | $ 25,700 | |||
Increase in valuation allowance | 100 | |||
Gross unrecognized tax benefits | 32,879 | $ 32,879 | $ 32,879 | |
Interest and penalties incurred during period | 1,700 | $ 900 | ||
Interest accrued | 6,800 | |||
Estimate of possible loss | $ 170,500 | |||
Income tax examination, estimate of possible loss, penalties expense | $ 63,700 | |||
Federal | ||||
Income Taxes [Line Items] | ||||
Net operating loss carryforwards | 3,000 | |||
Non-U.S. | ||||
Income Taxes [Line Items] | ||||
Net operating loss carryforwards | 100 | |||
State | ||||
Income Taxes [Line Items] | ||||
Net operating loss carryforwards | 7,500 | |||
Research Tax Credit Carryforward | State | ||||
Income Taxes [Line Items] | ||||
Tax credit carryforward | $ 13,400 |
Income Taxes (Significant Compo
Income Taxes (Significant Components of Deferred Tax Assets and Liabilities) (Details) - USD ($) $ in Thousands | Mar. 25, 2023 | Mar. 26, 2022 |
Deferred tax assets: | ||
Accrued expenses and allowances | $ 7,913 | $ 6,517 |
Net operating loss carryforwards | 1,132 | 1,713 |
Research and development tax credit carryforwards | 13,283 | 15,230 |
Stock-based compensation | 24,842 | 18,952 |
Lease liabilities | 21,602 | 26,653 |
Capitalized research and development | 9,183 | 6,372 |
Other | 1,119 | 651 |
Total deferred tax assets | 79,074 | 76,088 |
Valuation allowance for deferred tax assets | (13,076) | (13,088) |
Net deferred tax assets | 65,998 | 63,000 |
Deferred tax liabilities: | ||
Depreciation and amortization | 3,395 | 3,574 |
Right of use asset | 19,226 | 25,744 |
Acquisition intangibles | 7,782 | 32,315 |
Other | 37 | 0 |
Total deferred tax liabilities | 30,440 | 61,633 |
Total net deferred tax assets | $ 35,558 | $ 1,367 |
Income Taxes (Reconciliation of
Income Taxes (Reconciliation of Unrecognized Tax Benefits) (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Mar. 25, 2023 | Mar. 26, 2022 | |
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] | ||
Beginning balance | $ 32,879 | $ 32,879 |
Additions based on tax positions related to the current year | 0 | 0 |
Reductions based on tax positions related to the prior years | 0 | 0 |
Ending balance | $ 32,879 | $ 32,879 |
Segment Information (Narrative)
Segment Information (Narrative) (Details) | 12 Months Ended |
Mar. 25, 2023 segment product_line | |
Segment Reporting [Abstract] | |
Number of reportable segments | segment | 1 |
Number of product lines | product_line | 2 |
Segment Information (Schedule o
Segment Information (Schedule of Sales by Geographic Location Based on the Sales Office Location) (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Mar. 25, 2023 | Mar. 26, 2022 | Mar. 27, 2021 | |
Revenues from External Customers and Long-Lived Assets [Line Items] | |||
Net sales | $ 1,897,617 | $ 1,781,460 | $ 1,369,230 |
China | |||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||
Net sales | 1,230,602 | 1,197,812 | 1,024,178 |
Hong Kong | |||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||
Net sales | 223,405 | 325,433 | 170,605 |
Vietnam | |||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||
Net sales | 93,760 | 72,162 | 10,115 |
South Korea | |||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||
Net sales | 93,177 | 51,606 | 42,403 |
India | |||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||
Net sales | 69,343 | 18,257 | 14,481 |
United States | |||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||
Net sales | 52,688 | 29,513 | 21,708 |
Rest of World | |||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||
Net sales | $ 134,642 | $ 86,677 | $ 85,740 |
Segment Information (Schedule_2
Segment Information (Schedule of Property, Plant, and Equipment, Net, by Geographic Location) (Details) - USD ($) $ in Thousands | Mar. 25, 2023 | Mar. 26, 2022 |
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Property and equipment, net | $ 162,972 | $ 157,077 |
United States | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Property and equipment, net | 132,633 | 118,847 |
United Kingdom | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Property and equipment, net | 20,675 | 28,612 |
Rest of World | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Property and equipment, net | $ 9,664 | $ 9,618 |